Page last updated: 2024-11-04

pentobarbital

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID4737
CHEMBL ID448
CHEBI ID7983
SCHEMBL ID24966
SCHEMBL ID11114711
MeSH IDM0016182

Synonyms (145)

Synonym
2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-
5-ethyl-5-(1-methylbutyl)malonylurea
mebumal
5-ethyl-5-(sec-pentyl)barbituric acid
nebralin
5-ethyl-5-(1-methylbutyl)barbituric acid
pentobarbituric acid
pentabarbitone
2,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-
5-ethyl-5-(1-methylbutyl)-2,6(1h,3h,5h)-pyrimidinetrione
nsc28708
rivadorm
ethaminal
neodorm
nsc-28708
barbituric acid, 5-ethyl-5-(1-methylbutyl)-
neodorm (new)
pentobarbitone
dorsital
nembutal
pentabarbital
wln: t6vmvmv fhj fy3&1 f2
mebubarbital
KBIO1_000992
DIVK1C_000992
5-ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione
5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1h,3h,5h)-trione
CHEBI:7983 ,
5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1h,5h)-dione
SPECTRUM_001783
OPREA1_143902
SPECTRUM5_001705
BSPBIO_003305
IDI1_000992
OPREA1_775730
brn 0087067
(+-)-5-ethyl-5-(1-methylbutyl)barbituric acid
hsdb 3151
ccris 7089
2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, (+-)-
pentobarbitale [dcit]
ethyl-propylmethylcarbinylbarbituric acid
pentobarbital (van)
pentobarbitone (van)
pentobarbitalum
barbituric acid, 5-ethyl-5-(2-pentyl)-
nsc 28708
neodorm (van)
nembutal (van)
einecs 200-983-8
aethaminalum
pentobarbiturate
pentobarbitalum [inn-latin]
76-74-4
C07422
pentobarbital
5-ethyl-5-(1-methylbutyl)-2,4,6(1h,3h,5h)-pyrimidinetrione
DB00312
nembutal (tn)
pentobarbital (usp/inn)
D00499
NCGC00096074-01
KBIO2_004834
KBIOGR_001008
KBIOSS_002267
KBIO2_007402
KBIO3_002807
KBIO2_002266
SPECTRUM4_000574
SPECTRUM3_001783
NINDS_000992
SPBIO_002201
SPECTRUM2_001991
SPECTRUM1900006
NCGC00096074-02
HMS2094E21
AKOS000277861
pentobarbital cii
CHEMBL448 ,
HMS503G05
bdbm50055935
dtxcid003435
dtxsid7023435 ,
cas-76-74-4
tox21_111555
pharmakon1600-01900006
nsc760434
nsc-760434
CCG-39476
5-24-09-00168 (beilstein handbook reference)
ec 200-983-8
pentobarbitale
pentobarbital [usp:inn:ban]
unii-i4744080ir
i4744080ir ,
STL367899
(plusmn)-pentobarbital
5-ethyl-5-(pentan-2-yl)-1,3-diazinane-2,4,6-trione
(rs)-pentobarbital
BRD-A44448661-001-01-4
gtpl5480
pentobarbital [who-dd]
pentobarbital [mart.]
pentobarbital cii [usp-rs]
(+/-)-5-ethyl-5-(1-methylbutyl)barbituric acid
pentobarbital [green book]
thiopental sodium impurity b [ep impurity]
2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, (+/-)-
pentobarbital [ep monograph]
pentobarbital [inn]
pentobarbital [vandf]
pentobarbital [orange book]
pentobarbital [mi]
pentobarbital [usp monograph]
pentobarbital [hsdb]
CCG-220564
SCHEMBL24966
SCHEMBL11114711
sedalixir (salt/mix)
component of synirin (salt/mix)
component of emesert (salt/mix)
continal (salt/mix)
phetobarbitone
(.+/-.))-pentobarbital
AKOS028114301
SR-01000317092-2
pentobarbital, united states pharmacopeia (usp) reference standard
SR-05000001789-1
sr-05000001789
pentobarbital, european pharmacopoeia (ep) reference standard
pentobarbital 0.1 mg/ml in methanol
pentobarbital 1.0 mg/ml in methanol
SBI-0052713.P002
HMS3713B10
Q409632
NCGC00344563-01
pentobarbital cii (usp-rs)
barbituric acid, 5-ethyl-5-(2-pentyl)
pentobarbituate
n05ca01
pentobarbitalum (inn-latin)
pentobarbital (usp monograph)
pentobarbital (mart.)
pentobarbital (usp:inn:ban)
pentobarbital (ep monograph)

Research Excerpts

Overview

Pentobarbital is a short-acting barbiturate with anticonvulsant and sedative-hypnotic properties. It is a euthanasia drug in doses of 2 to 10 grams, causing death within 15-30 minutes. Oral pentobarbina is an effective and safe sedative for pediatric transthoracic echocardiography. Pentobarbna is a second-tier treatment that can be used to treat RICH.

ExcerptReferenceRelevance
"Pentobarbital sleep time is an in vivo assay of Phase I hepatic metabolism that can be induced by exposure to barbiturates and monoterpenes."( Selecting goats for juniper consumption did not improve their liver Phase I detoxification.
Cahill, NC; Quadros, DG; Shoemake, BM; Thorne, JW; Walker, JW, 2023
)
1.63
"Pentobarbital is a short-acting barbiturate with anticonvulsant and sedative-hypnotic properties. "( Liquid Chromatography-Tandem Mass Spectrometry for Quantitation of Serum Pentobarbital.
Kyle, PB; Yahya, HA, 2024
)
3.12
"Pentobarbital (PB) is a euthanasia drug in doses of 2 to 10 grams, causing death within 15-30 minutes. "( Deliberate Self-poisoning with a Lethal Dose of Pentobarbital with Confirmatory Serum Drug Concentrations: Survival After Cardiac Arrest with Supportive Care.
Druda, DF; Gone, S; Graudins, A, 2019
)
2.21
"Pentobarbital is a barbiturate, acting as a central nervous system depressant (CNS), being used for its anticonvulsant, sedative, hypnotic and anaesthetic properties. "( Pentobarbital in the context of possible suicides: Analysis of a Case.
Castro, A; Costa, P; Franco, JM; Melo, P; Quintas, MJ; Tarelho, S; Teixeira, HM, 2017
)
3.34
"Oral pentobarbital is an effective and safe sedative for pediatric transthoracic echocardiography. "( The efficacy and safety of oral pentobarbital sedation in pediatric echocardiography.
Bernard, PK; Kimball, TR; Warden, CN, 2010
)
1.16
"Pentobarbital sodium coma is a second-tier treatment that can be used to treat RICH."( Pentobarbital sodium coma for refractory intracranial hypertension.
Censullo, JL; Sebastian, S, 2003
)
2.48
"Pentobarbital is a more effective agonist than GABA only when receptors contain an alpha6 subunit."( Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital.
Drafts, BC; Fisher, JL, 2006
)
1.27
"Pentobarbital is an anesthetic used mainly in animal studies."( The reduction of tumor necrosis factor-alpha release and tissue damage by pentobarbital in the experimental endotoxemia model.
Chen, HI; Harn, HJ; Hsu, BG; Lee, RP; Li, CH; Liao, KW; Lin, SZ; Tsai, NM; Yang, FL, 2007
)
1.29
"Pentobarbital is a hypnotic drug commonly used as anesthesia for in vivo studies in various animals. "( Effect of pentobarbital on contractility of mouse skeletal muscle.
Abresch, RT; Fowler, WM; Lieberman, JS; Portwood, MM; Taylor, RG, 1984
)
2.11
"Pentobarbital coma (PBC) is a treatment for patients with refractory status epilepticus, but there are currently few guidelines for choosing when to initiate or continue this therapy. "( Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus.
Lowenstein, DH; Yaffe, K, 1993
)
2.04
"Pentobarbital sodium is a widely used anesthetic for animal experiments. "( No suppression of respiratory function of mitochondrial isolated from the hearts of anesthetized rats with high-dose pentobarbital sodium.
Kawatani, Y; Nakahara, H; Suga, H; Takaki, M; Utsumi, K, 1997
)
1.95
"Pentobarbital is a sedative hypnotic which is used in the treatment of people suffering from anxiety related conditions and to manage elevated intracranial pressures and cerebral ischemia due to neurosurgical procedures. "( Capillary electrophoresis stereoselective determination of R-(+)- and S-(-)-pentobarbital from serum using hydroxypropyl-gamma-cyclodextrin, solid-phase extraction and ultraviolet detection.
Bartlett, MG; Srinivasan, K, 1997
)
1.97
"Pentobarbital acts as a mixed inhibitor of net D-glucose exit, as monitored photometrically from human red cells. "( Interactions of sodium pentobarbital with D-glucose and L-sorbose transport in human red cells.
Arain, M; Naftalin, RJ, 1999
)
2.06
"Pentobarbital is a useful adjunct for intracranial pressure control in advanced metabolic coma."( Pentobarbital therapy for intracranial hypertension in metabolic coma. Reye's syndrome.
Kaufman, NM; Marshall, LF; Rauscher, A; Shapiro, HM,
)
2.3
"Pentobarbital acts as a cerebral radioprotectant, but the selectivity of its protection for the central nervous system has not been demonstrated."( Enhancement of the efficacy of x-irradiation by pentobarbital in a rodent brain-tumor model.
Delaney, T; Friedman, R; Oldfield, EH; Olson, JJ; Orr, K, 1990
)
1.26
"Pentobarbital sodium is a widely used anesthetic agent that has been demonstrated to attenuate systemic vascular responses to multiple pressors. "( Pentobarbital attenuates pulmonary vasoconstriction in isolated sheep lungs.
Martin, LD; Wetzel, RC, 1989
)
3.16

Effects

Pentobarbital has a profound effect on brain lipid metabolism. The block of neuromuscular transmission is due primarily to a suppression of the end-plate sensitivity to acetylcholine.

Pentobarbital therapy has been associated with decreased urinary nitrogen excretion and resting energy expenditure in stressed patients. PentobarBital has been reported as both increasing and decreasing the effects of noise trauma on the inner ear.

ExcerptReferenceRelevance
"Pentobarbital has a profound effect on brain lipid metabolism. "( Effects of pentobarbital on incorporation of plasma palmitate into rat brain.
Bell, JM; DeGeorge, JJ; Rapoport, SI; Yamazaki, S, 1994
)
2.12
"Pentobarbital has a dual action on both quantal content and end-plate membrane depending on the concentration, and the block of neuromuscular transmission is due primarily to a suppression of the end-plate sensitivity to acetylcholine."( Mechanism of blockade of neuromuscular transmission by pentobarbital.
Narahashi, T; Seyama, I, 1975
)
1.22
"Pentobarbital has been shown to reduce the time to sleep onset, decrease the number of body movements during sleep and spontaneous awakenings and increase the total sleep time."( The use of pentobarbital in cases of severe delirium: a case series.
Hang, PC; Holahan, T; Kerr, CW; Luczkiewicz, DL; Milch, R, 2014
)
1.51
"PO pentobarbital has comparable effectiveness and a lower rate of respiratory complications compared with IV pentobarbital in infants younger than 12 months; its use should be considered, regardless of presence of an IV catheter."( Infant sedation for MR imaging and CT: oral versus intravenous pentobarbital.
Burrows, PE; Connor, L; Fontaine, PJ; Karian, VE; Mason, KP; Sanborn, PA; Zurakowski, D, 2004
)
1.18
"Pentobarbital anesthesia has been observed to increase markedly the effectiveness of respiration of oxygen at 3 atmospheres of pressure absolute to increase the response of early generation isotransplants of C3H mouse tumors to two-dose irradiation. "( On the mechanism for enhancement of tumor radiation to hyperbaric oxygen in sodium pentobarbital anesthetized rodents.
Biaglow, JE; Dosoretz, DE; Durand, RE; Suit, HD, 1984
)
1.94
"Pentobarbital has been reported as both increasing and decreasing the effects of noise trauma on the inner ear. "( Effects of noise, hypothermia and barbiturate on cochlear electrical activity.
Henry, KR, 1980
)
1.7
"Pentobarbital has a profound effect on brain lipid metabolism. "( Effects of pentobarbital on incorporation of plasma palmitate into rat brain.
Bell, JM; DeGeorge, JJ; Rapoport, SI; Yamazaki, S, 1994
)
2.12
"The pentobarbital has been reported to induce neobiogenesis of mitochondria with enhancement of mitochondrial DNA synthesis."( [Effect of pentobarbital on ADP ribosylation].
Masmoudi, AS,
)
1
"Pentobarbital has a dual action on both quantal content and end-plate membrane depending on the concentration, and the block of neuromuscular transmission is due primarily to a suppression of the end-plate sensitivity to acetylcholine."( Mechanism of blockade of neuromuscular transmission by pentobarbital.
Narahashi, T; Seyama, I, 1975
)
1.22
"Pentobarbital has recently been shown to be a cerebral radioprotectant in the rodent and primate models of single fraction radiation injury."( The cerebral radioprotective effect of alternative barbiturates to pentobarbital.
DeLaney, T; Oldfield, EH; Olson, JJ; Orr, K; Shelley, C, 1992
)
1.24
"Pentobarbital has been used in the majority of the clinical studies."( Management of elevated intracranial pressure.
LeBlanc, KL; Woster, PS, 1990
)
1
"Pentobarbital therapy has been associated with decreased urinary nitrogen excretion and resting energy expenditure in stressed patients. "( Pentobarbital improves nitrogen retention in sepsis.
Buzby, GP; Daniel, MG; Dickerson, RN; Fried, RC; Mullen, JL; Stein, TP,
)
3.02

Actions

Pentobarbital does not increase the excitatory postsynaptic potential slope at any given stimulus strength. It blocks the increase in CBF produced by physostigmine, but had no effect on that produced by pilocarpine.

ExcerptReferenceRelevance
"Pentobarbital sodium can suppress respiration partly via GABAA receptors."( [Effects of pentobarbital sodium on rhythmical respiration of neonatal rat medullary preparations].
Chen, J; Wu, ZH; Zou, ZP, 2006
)
2.16
"Pentobarbital-induced increase of heart rate variability and prolongation of ECG intervals are seen in both beta3(N265M) mice and wild-type mice, suggesting that they are not dependent on beta3-containing GABAA receptors."( Identification of a molecular target mediating the general anesthetic actions of pentobarbital.
Arras, M; Jurd, R; Rudolph, U; Zeller, A, 2007
)
1.29
"Pentobarbital did not increase the excitatory postsynaptic potential slope at any given stimulus strength."( Low concentrations of pentobarbital enhance excitability of rat hippocampal neurons.
Archer, DP; Roth, SH, 2007
)
1.38
"Pentobarbital may produce its effects by an additional action on postsynaptic neurone membranes."( Pain-depressing agents and the spinal nociceptive system.
Jurna, I, 1984
)
0.99
"Pentobarbital blocked the increase in CBF produced by physostigmine, but had no effect on that produced by pilocarpine."( Cholinergic cerebral vasodilatation: lack of involvement of cranial parasympathetic nerves.
Rubinstein, EH; Scremin, OU; Sonnenschein, RR, 1983
)
0.99
"Pentobarbital was found to inhibit both the spontaneous mechanical activity and the basal tone of these vessels."( Effect of pentobarbital on the reactivity of isolated human cerebral arteries.
Benitez, J; Lobato, RD; Marín, J; Rico, ML; Salaices, M, 1981
)
1.39
"Pentobarbital and Sulpiride produce a biphasyc effect of opposite sign: at small doses Pentobarbital increases the stretch response while Sulpiride reduces it."( [Action of some psychotropic drugs on the electrmyographic response evoked by stretches of the gastrocnemius muscle of rats submitted to stress].
Eandi, M; Ricci Gamalero, S; Taglia, P, 1980
)
0.98
"Pentobarbital and midazolam produce ethanol-like discriminative stimulus effects in male and female cynomolgus monkeys suggesting a significant GABA(A) component mediating the behavioral effects of ethanol. "( Characterization of the discriminative stimulus effects of GABA(A) receptor ligands in Macaca fascicularis monkeys under different ethanol training conditions.
Azarov, A; Grant, KA; Green-Jordan, K; Szeliga, KT; Waters, CA, 2000
)
1.75
"Pentobarbital did not suppress TSH at room temperature."( Effects of ether and pentobarbital anesthesia on thyroid function in the rat.
Bray, GA; Ohtake, M, 1977
)
1.3
"Pentobarbital tended to increase the latency of the evoked wave, an effect not seen with delta9-THC."( Effects of delta9-tetrahydrocannabinol and pentobarbital on a cortical response evoked during conditioning.
Boyd, EH; Boyd, ES; Brown, LE, 1976
)
1.24
"Pentobarbital did not increase killing."( Chlordiazepoxide and diazepam induced mouse killing by rats.
Corcia, RM; Gay, PE; Lamon, S; Leaf, RC; Wnek, DJ, 1975
)
0.98
"Pentobarbital prevented the increase in ODC mRNA, whereas the glutamate antagonist MK-801 had no effect on the elevation of ODC gene expression after ischemia."( Modulation of ornithine decarboxylase mRNA following transient ischemia in the gerbil brain.
Carney, JM; Dempsey, RJ; Kindy, MS, 1991
)
1

Treatment

Posttreatment with pentobarbital suppressed the activities of NF-kappaB and iNOS, decreased BUN, Cre, GOT, GPT, CPK levels, and decreased the markers of kidney injury after rhabdomyolysis. Pretreatment with pentbarbital (30 mg/kg, IP) twice daily for 2 and 6 days partially reversed this effect of calcium.

ExcerptReferenceRelevance
"In pentobarbital-treated mice, jujubosides significantly augmented the hypnotic effect of pentobarbital (45 mg/kg, i.p.), proved by increasing sleep time and this augmentative effect was potentiated by 5-hydroxytryptophan (2mg/kg, i.p.)."( Hypnotic effect of jujubosides from Semen Ziziphi Spinosae.
Bai, YJ; Cao, JX; Cui, SY; Cui, XY; Zhang, J; Zhang, QY; Zhang, YH; Zhao, YY, 2010
)
0.87
"Pentobarbital treatment resulted in two-fold increases in neuron survival in culture after 2 and 4 h postmortem compared to non-anesthetic controls, but was not as effective as simple postmortem treatment on ice and therefore not essential."( Postmortem effect of pentobarbital anesthetic on survival of adult cortical neurons in primary culture.
Brewer, GJ; McManus, DQ; Viel, JJ, 2004
)
1.36
"Pentobarbital treatment led to deceleration of breathing, the frequency range of respiratory oscillations of RR and AV intervals shifted in some cases from high to low frequencies; evaluation of spectral power in the intermittent band corresponding to respiration frequency (instead of standard fixed high-frequency band) showed that pentobarbital suppressed the respiratory oscillations in these bands."( Effect of pentobarbital on spectral characteristics and phase ratios of wave oscillations of cardiac contraction period and time of atrioventricular conduction in cats.
Alipov, NN; Bobrova, NA; Kuznetsova, TE; Sergeeva, OV; Smirnov, VM, 2006
)
1.46
"Pentobarbital treatment reduced 2-DG accumulation in all brain areas examined and these reductions were not influenced by the nBM lesions."( Deoxyglucose uptake and choline acetyltransferase activity in cerebral cortex following lesions of the nucleus basalis magnocellularis.
Fibiger, HC; Lamarca, MV, 1984
)
0.99
"Pentobarbital (PB) treatment (30 mg/kg, ip) concomitant with ULO at 10.00-11.00 hr on diestrus III did not prevent progesterone to increase at 12.00-13.00 hr."( Involvement of the adrenals in ovulation induced by unilateral ovariectomy in the rat.
Aron, C; Roos, J, 1981
)
0.98
"Pentobarbital treatment, which inhibits hypothalamic input and the LH surge, prevented the gonadotropin surge-associated increase in GnRH-R mRNA levels in E-primed OVX rats."( Roles of estrogen, progesterone, and gonadotropin-releasing hormone (GnRH) in the control of pituitary GnRH receptor gene expression at the time of the preovulatory gonadotropin surges.
Bauer-Dantoin, AC; Jameson, JL; Weiss, J, 1995
)
1.01
"In pentobarbital-treated rats, the sensitivity of the cardiovascular system to nicotine was decreased; in these rats, consecutive nicotine doses did show tachyphylaxis for the pressor and tachycardiac responses."( Cardiovascular effects of different schedules of nicotine administration on spinal rats: influence of pentobarbital.
Cruz, SL; Fernández-Guasti, A; Villarreal, JE, 1994
)
1.02
"In pentobarbital-treated animals, regardless of the extent of heparinization, consistent translocation to both MLN and distant organs occurred when shock was prolonged for 90 min, and assessment of translocation was made 24 hr after reinfusion of shed blood."( Reevaluation of the linkage between acute hemorrhagic shock and bacterial translocation in the rat.
Chen, CY; Cocanour, CS; LaRocco, MT; Miller, TA; Myers, SI; Reed, RL; Rodriguez, LF; Russell, DH; Smith, GS, 1993
)
0.8
"Pentobarbital treatment prevented the E-induced increase in follistatin mRNA levels, suggesting that the effects of E are mediated via GnRH or other hypothalamic factors."( Gonadotropin-releasing hormone regulation of pituitary follistatin gene expression during the primary follicle-stimulating hormone surge.
Bauer-Dantoin, AC; Jameson, JL; Weiss, J, 1996
)
1.02
"Pentobarbital is standard treatment for refractory status epilepticus (SE) and is almost uniformly effective, but the morbidity of treatment and the mortality of refractory SE are high. "( Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus.
Drislane, FW; Krishnamurthy, KB, 1996
)
1.74
"Pentobarbital treatment resulted in marked, qualitative differences after both protocols."( Pentobarbital alters the response of cerebrospinal fluid pressure evoked by two provocative tests in rats.
Davis, RA; Searles, RV; Severs, WB, 1996
)
2.46
"In pentobarbital-treated dogs, L-734,217 plasma concentrations during the first 3 h collection period were significantly higher than those in the control animals."( Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734,217, in dogs.
Cook, JJ; Ellis, JD; Hand, EL; Holahan, MA; Prueksaritanont, T; Sitko, GR; Stranieri, MT, 1997
)
1.2
"The pentobarbital treatment did not significantly alter the affinity of the radioligand to the receptor in the hippocampus and the expression of beta 1 mRNA in CA3 and CA4."( Effects of pentobarbital on the expression of GABAA receptor beta 1 mRNA in the hippocampus: differential responses of CA1 and CA3.
Lee, YP; Yin, HS, 1998
)
1.17
"Pentobarbital pretreatment failed to suppress FLI."( Pre- versus postinjury effects of intravenous GABAergic anesthetics on formalin-induced Fos immunoreactivity in the rat spinal cord.
Coderre, TJ; Gilron, I; Quirion, R, 1999
)
1.02
"Pentobarbital-treated rats received i.v."( Evidence suggesting that the potentiating action of neuropeptide Y on luteinizing hormone (LH)-releasing hormone-induced LH release remains unaltered in aged female rats.
Sahu, A, 2000
)
1.03
"Pentobarbital pretreatment of hypoxic rats resulted in further diminution of 5-HT degradation after probenecid, having synergistic character in pons with medulla, which points to the specific sensitivity of serotonergic system in the latter area."( Effect of pentobarbital anesthesia on serotonin metabolism in hypoxic rat brain.
Zaleska, M,
)
1.26
"Pentobarbital treatment blocked the increase in the number of GnRH mRNA-expressing cells normally observed at 1800 h in saline-treated controls, suggesting that the increase in GnRH gene expression is closely coupled to secretion of GnRH from the hypothalamus."( Gonadotropin-releasing hormone gene expression during the rat estrous cycle: effects of pentobarbital and ovarian steroids.
Gugneja, S; Mayo, KE; Park, OK, 1990
)
1.22
"Pentobarbital pretreatment on day 1 resulted in rapid tolerance to pentobarbital on day 2."( Rapid tolerance as an index of chronic tolerance.
Kalant, H; Khanna, JM; Shah, G; Weiner, J, 1991
)
1
"Pentobarbital pretreatment may be used to predict biochemical events involved in ischemic brain damage following bilateral carotid artery ligations in the gerbil, since it reduces the subsequent edema and mortality. "( Arachidonic acid metabolism in gerbil cerebra: effects of ischemia and pentobarbital.
Dorman, RV; Hamm, TF, 1990
)
1.95
"Pentobarbital treatment by itself increased MHPG-SO4 levels in the thalamus, locus coeruleus (LC) region, midbrain and basal ganglia of nonstressed rats."( Pentobarbital attenuates stress-induced increases in noradrenaline release in specific brain regions of rats.
Ida, Y; Satoh, M; Tanaka, M; Tsuda, A; Tsujimaru, S, 1990
)
2.44
"In pentobarbital-treated fasted rats, the incorporation of both alanine and pyruvate into circulating glucose and into hepatic glycogen and acylglycerol glycerol was increased."( Pregnancy and pentobarbital anaesthesia modify hepatic synthesis of acylglycerol glycerol and glycogen from gluconeogenic precursors during fasting in rats.
Herrera, E; Zorzano, A, 1988
)
1.15
"Pentobarbital pretreatment reportedly either inhibits, enhances or has no effect on morphine analgesia. "( Potentiation of morphine analgesia by subanesthetic doses of pentobarbital.
Misra, AL; Pontani, RB; Vadlamani, NL, 1985
)
1.95
"Pentobarbital treatment slightly decreased biliary bile acid excretion in BD rats, but caused a 60% increase in bile flow."( Acute effects of pentobarbital-anaesthesia on bile secretion.
Dijkstra, T; Havinga, R; Kuipers, F; van Asselt, W; Vonk, RJ, 1985
)
1.33
"Posttreatment with pentobarbital decreased blood BUN, Cre, GOT, GPT, CPK levels, decreased the markers of kidney injury, and suppressed the release of NF-kappaB and iNOS after rhabdomyolysis."( Pentobarbital reduces rhabdomyolysis-induced acute renal failure in conscious rats.
Hsu, BG; Lee, CJ; Lee, RP; Subeq, YM; Wu, WT; Yang, FL, 2009
)
2.11
"Posttreatment with pentobarbital suppressed the activities of NF-kappaB and iNOS, decreased BUN, Cre, GOT, GPT, CPK levels, and decreased the markers of kidney injury after rhabdomyolysis. "( Pentobarbital reduces rhabdomyolysis-induced acute renal failure in conscious rats.
Hsu, BG; Lee, CJ; Lee, RP; Subeq, YM; Wu, WT; Yang, FL, 2009
)
2.12
"Pretreatment with pentobarbital diminished the L-DOPA-induced DA increase."( Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
Adachi, YU; Doi, M; Higuchi, H; Kazama, T; Sato, S; Satomoto, M; Watanabe, K; Yamada, S, 2006
)
2.1
"treatment with pentobarbital (3-5.6 mg/kg) or chlordiazepoxide (10-30 mg/kg)."( Histamine as a punisher in squirrel monkeys: effects of pentobarbital, chlordiazepoxide and H1- and H2-receptor antagonists on behavior and cardiovascular responses.
Goldberg, SR, 1980
)
0.85
"Pretreatment with pentobarbital 250 micrograms prevented the facilitation by naloxone of C fibre-evoked activity."( Effects of intrathecally administered pentobarbital and naloxone on the activity evoked in ascending axons of the rat spinal cord by stimulation of afferent A and C fibres. Further evidence for a tonic endorphinergic inhibition in nociception.
Bernatzky, G; Doi, T; Jurna, I, 1983
)
0.86
"Pretreatment with pentobarbital (30 mg/kg, IP) twice daily for 2 and 6 days partially reversed this effect of calcium, suggesting that calcium and pentobarbital may in part exert their depressant effect by a similar mechanism."( Effect of calcium on locomotor activity of mice.
Fung, YK; Uretsky, NJ, 1980
)
0.58
"Treatment of pentobarbital-anaesthetized rats with captopril (SQ 14225) caused a reduction in mean arterial blood pressure (MAP), which lasted for over 1 h when a dose of 5 mg/kg i.p was used. "( The effect of prostaglandin synthesis inhibition of the acute blood pressure reduction by captopril in pentobarbital-anaesthetized rats.
Provoost, AP, 1980
)
0.85
"The treatment of pentobarbital caused a significant alteration in the binding of [3H]naloxone and [3H]muscimol in various brain areas 5 h after ischemia."( Effect of pentobarbital on postischemic MK-801, muscimol, and naloxone bindings in the gerbil brain.
Araki, T; Kanai, Y; Kato, H; Kogure, K, 1994
)
1.02
"Treatment with pentobarbital produced a 12% decrease in the hybridization signal."( Negative regulation of proopiomelanocortin gene expression by GABAA receptor activation in the rat arcuate nucleus.
Garcia de Yebenes, E; Pelletier, G, 1994
)
0.63
"Treatment with pentobarbital produced a 24% decrease in the hybridization signal."( Chronic administration of muscimol and pentobarbital decreases gonadotropin-releasing hormone mRNA levels in the male rat hypothalamus determined by quantitative in situ hybridization.
Li, S; Pelletier, G, 1993
)
0.89
"Pretreatment with pentobarbital (40 mg/kg, i.p.) greatly reduced or inhibited the induction of HSP70 and HSC70 mRNAs at both early (3-h) and late (2-day) phases after ischemia."( Reduction of HSP70 and HSC70 heat shock mRNA induction by pentobarbital after transient global ischemia in gerbil brain.
Abe, K; Kawagoe, J; Kogure, K, 1993
)
0.85
"Treatment with pentobarbital of primary cultured cerebellar granule cells decreased the gamma-aminobutyric acid, (GABA)A receptor subunit gamma-2 long/short (gamma-2L/S) mRNA ratio. "( Pentobarbital decreases the gamma-aminobutyric acidA receptor subunit gamma-2 long/short mRNA ratio by a mechanism distinct from receptor occupation.
Bhave, SV; Hoffmann, E; Hoffmann, PL; Olsen, RW; Tabakoff, B; Tobin, AJ; Tyndale, RF, 1997
)
2.09
"Pretreatment with pentobarbital also prevented or strongly reduced changes in cyclic GMP levels elicited by excitatory drugs without abolishing the tremorigenic effects of harmaline and oxotremorine."( Effects of stimulatory and depressant drugs on cyclic guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate levels in mouse brain.
Dinnedahl, V; Gumulka, SW; Opmeer, FA; Schönhöfer, PS, 1976
)
0.58
"Pretreatment with pentobarbital Na (30 mg/kg, i.p.), hopantenate Ca (100 mg/kg, i.p.), vinpocetine (5 mg/kg, i.p."( Carbon monoxide (CO)-induced hypoxia in mice: evaluation as an experimental model of cerebral ischemia for drug screening.
Hiramatsu, Y; Kato, Y; Koida, M; Muguruma, K; Nakamuta, H; Ogawa, Y; Yasuda, K, 1989
)
0.6
"Pretreatment with pentobarbital inhibited the Shosaikoto-induced decrease of plasma AD levels."( Effect of shosaikoto on plasma catecholamines.
Amagaya, S; Ogihara, Y, 1989
)
0.6
"Treatment with pentobarbital (35 mg/kg at 12:00 h) blocked the proestrous surges of LH and progesterone and resulted in pulsatile LH secretion during estrus."( Role of proestrous progesterone secretion in suppressing basal pulsatile LH secretion during estrus of the estrous cycle.
Chatterton, RT; Fox, SR; Smith, MS, 1989
)
0.62
"Mice treated with pentobarbital showed a graded response to increasing levels of heat but were unresponsive to either morphine or naloxone."( The general anesthesia induced by various drugs differentially affects analgesia and its variability.
Banks, WA; Galina, ZH; Kastin, AJ; Trentman, TL, 1988
)
0.6
"Treatment with pentobarbital or dimethyl sulfoxide prevented intracranial pressure elevations but had no protective effect on survival."( Effects of therapeutic agents in a rabbit model of Reye syndrome.
Adams, HR; Trauner, DA,
)
0.47

Toxicity

LD50 of strychnine and hypnotic ED50 of pentobarbital sodium with or without theanine for mice were tested according to Bliss' case. Naltrexone (10 mg/kg, ip) given 5 min before pentobarBital did not alter the LD 50 of the latter.

ExcerptReferenceRelevance
" Naltrexone (10 mg/kg, ip) given 5 min before pentobarbital did not alter the LD50 of the latter."( Studies of the possible role of brain endorphins in pentobarbital anesthesia and toxicity in mice.
Bhargava, HN, 1979
)
0.77
" It is concluded that haemoperfusion through this column is a safe and simple procedure, which merits evaluation in the treatment of severe drug overdose in man."( The safety assessment in the dog of a charcoal haemoperfusion column.
Fennimore, J; Kolthammer, JC; Lang, S; Watson, PA, 1976
)
0.26
"The effect of particle size on the time elapsing between administration and loss of righting reflex and % of deaths by determining the LD50 has been studied in mice."( Biopharmaceutical factors influencing LD50. Part II: Particle size.
Ring, PE; Ritschel, WA; Siegel, EG, 1975
)
0.25
" Three minutes after pretreatment, group 1 (n = 11), group 3 (n = 10), and their respective control groups (n = 11 and n = 9) received intravenous bupivacaine LD50 (median lethal dose)."( Nimodipine reduces the toxicity of intravenous bupivacaine in rats.
Horn, JL; Hyman, SA; Kambam, JR; Kinney, WW; Skelley, CC, 1992
)
0.28
" The adverse changes noted following the low dose of D-DCVC were due to its direct renal actions and not to extrarenal actions such as major changes in blood gases, total renal blood flow or mean arterial blood pressure that could have indirectly contributed to renal damage via induction of episodes of renal ischemia or hypoxia."( Acute effects of the D-isomer of S-(1,2-dichlorovinyl)cysteine on renal function and ultrastructure in the pentobarbital-anesthetized dog: site-specific toxicity involving the S1 and S2 cells of the proximal tubule.
Koechel, DA; Krejci, ME; Ridgewell, RE, 1991
)
0.49
" The results indicated that 4-methyl-2,3-dihydrofuran and 4-ethyl-2,3-dihydrofuran were toxic to the lung whereas 4-pentyl-2,3-dihydrofuran did not produce lung toxicity."( Toxicity of alkyldihydrofurans to metabolically active organs in the mouse.
Bresnahan, J; Brinkman, R; Gammal, L; Penka, V; Traiger, G; Wiley, R; Zenk, P, 1990
)
0.28
"Administration of phenobarbital, benzonal and benzobamil in a dose of 1/20 of LD50 to rats was shown to be followed by phase changes in the system of microsomal oxidation of the liver--activation in the first days after administration with the subsequent (in 1-3 months) decrease of the activity."( [Effect of anticonvulsant agents, inducers of microsomal oxidation, on the B-link of immunity and on the natural cytotoxicity of lymphoid organ cells in rats].
Cherevko, NA; Galenko, OA; Novozheeva, TP; Potapova, GV; Saratikov, AS,
)
0.13
" The aim of acute toxicity was, up to now, to determine LD50 level or eventually a minimal lethal dose."( Grip strength test and infrared thermometry as non-invasive methods to complement acute toxicity data in mice.
Nordmann, H, 1985
)
0.27
"The intravenous LD50 of the hypothalamic tetradecapeptide somatostatin was determined in mice and rats of both sexes."( Sex-related toxicity of somatostatin and its interaction with pentobarbital and strychnine.
Antonetti, F; Borrelli, F; Cantelmo, A; Caprino, L, 1983
)
0.51
"We evaluated the hypothesis that the area postrema facilitates the cardiac arrhythmias caused by toxic doses of digitalis."( Lack of protection against ouabain cardiotoxicity after chronic ablation of the area postrema in cats.
Borison, HL; Riancho, JA; Thron, CD, 1984
)
0.27
"The oral LD50 of hymenoxon in Swiss white mice was found to be 241 +/- 37 mg/kg."( Toxicity and mutagenicity of hymenoxon, sequiterpene lactone.
Jones, DH; Kim, HL, 1981
)
0.26
" Furthermore, a lack of central nervous system cellular tolerance was demonstrated by the finding that intracerebroventricular LD50 values for propoxyphene in propoxyphene- and water-treated mice were identical to the value derived from naive mice."( Effect of repeated oral propoxyphene administration on analgesia, toxicity and microsomal metabolism in the mouse.
Masten, LW, 1980
)
0.26
"Twenty-four hour LD50 values of secobarbital, pentobarbital, phenobarbital, in male Swiss-Webster mice weighing approximately 30 g each."( Twenty-four hour toxicity rhythms of sedative-hypnotic drugs in mice.
Ross, FH; Sermons, AL; Walker, CA, 1980
)
0.52
" We believed that this represented an adverse effect that was probably related to the study drug and the study was stopped."( Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema.
Aranda, M; Giannotta, SL; Levy, ML; Zelman, V, 1995
)
0.29
" None of the protective drugs inhibited the initial 5-HT loss following MDMA, rendering unlikely any proposal that they are protective because they inhibit 5-HT release and the subsequent formation ofa toxic indole derivative."( A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
Colado, MI; Green, AR, 1994
)
0.29
" SPB pretreatment elevated the LD50 of DEPA to 1780 and 1535 mg/kg in mice and rats respectively and 85% rats survived when SPB was injected 5 min after acute oral exposure to DEPA (1000 mg/kg)."( Acute oral toxicity of insect repellent N,N-diethylphenylacetamide in mice, rats and rabbits and protective effect of sodium pentobarbital.
Kaveeshwar, U; Purkayastha, SS; Rao, SS, 1993
)
0.49
" These extrarenal changes were accompanied by adverse changes in renal function, ultrastructural damage to S1, S2 and S3 cells of the proximal tubule and to thick ascending limb cells and an impaired ability of the kidneys to respond to a known diuretic--ethacrynic acid (EA)."( Extrarenal and direct renal actions of atractyloside contribute to its acute nephrotoxicity in pentobarbital-anesthetized dogs.
Koechel, DA; Krejci, ME, 1993
)
0.5
"Sedation of children can be done in a safe and highly efficacious manner in a hospital radiology department using a structured sedation program modeled after the guidelines of the American Academy of Pediatrics."( Safety and efficacy of sedation in children using a structured sedation program.
Ball, WS; Egelhoff, JC; Koch, BL; Parks, TD, 1997
)
0.3
" The intraperitoneal LD50 was found to be 575 mg/kg."( Acute toxicity and general pharmacological effect on central nervous system of the crude rhizome extract of Kyllinga brevifolia Rottb.
Ferro, EA; Heinichen, O; Helliön-Ibarrola, MC; Ibarrola, DA; Montalbetti, Y; Villalba, D, 1999
)
0.3
" The extract was thus devoid of overt acute and subchronic toxic effects, and did not affect CYPs and GSH whose modulation may cause interactions of components in a multiple drug therapy."( Acute and subchronic evaluation of Indigofera arrecta: absence of both toxicity and modulation of selected cytochrome P450 isozymes in ddY mice.
Ankrah, NA; Nyarko, AK; Ofosuhene, M; Sittie, AA, 1999
)
0.3
"The practice of administering oral contrast material in children before sedation for abdominal CT appears to be safe when using the sedation drugs and protocols in place at our institution."( Is administration of enteric contrast material safe before abdominal CT in children who require sedation? Experience with chloral hydrate and pentobarbital.
Donnelly, LF; Fricke, BL; Ziegler, MA, 2003
)
0.52
" We characterize the fasting status of patients receiving procedural sedation and analgesia in a pediatric ED and assess the relationship between fasting status and adverse events."( Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department.
Agrawal, D; Gupta, R; Krauss, B; Manzi, SF, 2003
)
0.32
" Preprocedural fasting state and adverse events were recorded."( Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department.
Agrawal, D; Gupta, R; Krauss, B; Manzi, SF, 2003
)
0.32
" Seventy-seven adverse events occurred in 68 (6."( Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department.
Agrawal, D; Gupta, R; Krauss, B; Manzi, SF, 2003
)
0.32
" There was no association between preprocedural fasting state and adverse events."( Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department.
Agrawal, D; Gupta, R; Krauss, B; Manzi, SF, 2003
)
0.32
"There are few studies on sedation medication requirements and sedation related adverse events in developmentally disabled children."( Sedation medication received and adverse events related to sedation for brain MRI in children with and without developmental disabilities.
Chen, X; Groebe, A; Kannikeswaran, N; Mahajan, PV; Sethuraman, U, 2009
)
0.35
"The objectives of our study were to compare sedation medication received and sedation related adverse events for brain magnetic resonance imaging (MRI) between children with and without developmental disabilities."( Sedation medication received and adverse events related to sedation for brain MRI in children with and without developmental disabilities.
Chen, X; Groebe, A; Kannikeswaran, N; Mahajan, PV; Sethuraman, U, 2009
)
0.35
" Data on developmental status, demographics and details of sedation medications received along with adverse events were collected."( Sedation medication received and adverse events related to sedation for brain MRI in children with and without developmental disabilities.
Chen, X; Groebe, A; Kannikeswaran, N; Mahajan, PV; Sethuraman, U, 2009
)
0.35
" Sedation data included adverse events, dosing, and failed sedation."( The efficacy and safety of oral pentobarbital sedation in pediatric echocardiography.
Bernard, PK; Kimball, TR; Warden, CN, 2010
)
0.64
"Oral pentobarbital is an effective and safe sedative for pediatric transthoracic echocardiography."( The efficacy and safety of oral pentobarbital sedation in pediatric echocardiography.
Bernard, PK; Kimball, TR; Warden, CN, 2010
)
1.16
" There were no significant adverse events in either cohort."( A comparison of the efficacy and safety of chloral hydrate versus inhaled anesthesia for sedating infants and toddlers for transthoracic echocardiograms.
Calfin, D; Cohen, MS; Jobes, DR; Jones, LA; Montenegro, LM; Nicolson, SC; O'Neill, D, 2010
)
0.36
"The objectives of this study were to describe the type and frequency of postdischarge adverse events related to sedation for elective diagnostic imaging in children and to determine if any patient or drug characteristics were associated with such adverse events."( Postdischarge adverse events related to sedation for diagnostic imaging in children.
Chen, X; Kaila, R; Kannikeswaran, N, 2012
)
0.38
" We administered a postdischarge adverse event questionnaire to families within 3 to 5 days after sedation to assess adverse events such as behavioral changes, vomiting, recovery time to baseline status, and need for medical follow-up."( Postdischarge adverse events related to sedation for diagnostic imaging in children.
Chen, X; Kaila, R; Kannikeswaran, N, 2012
)
0.38
"4% patients experienced postdischarge adverse events."( Postdischarge adverse events related to sedation for diagnostic imaging in children.
Chen, X; Kaila, R; Kannikeswaran, N, 2012
)
0.38
"Postdischarge adverse events related to sedation for diagnostic imaging are minor, mostly behavioral, but occur in a significant number of patients."( Postdischarge adverse events related to sedation for diagnostic imaging in children.
Chen, X; Kaila, R; Kannikeswaran, N, 2012
)
0.38
" LD50 of strychnine and hypnotic ED50 of pentobarbital sodium with or without theanine for mice were tested according to Bliss' case."( Theanine enhanced both the toxicity of strychnine and anticonvulsion of pentobarbital sodium.
Gao, JC; Wu, BL; Yang, W; Yu, XC, 2016
)
0.93
" Theanine attenuated the LD50 of strychnine."( Theanine enhanced both the toxicity of strychnine and anticonvulsion of pentobarbital sodium.
Gao, JC; Wu, BL; Yang, W; Yu, XC, 2016
)
0.67
"Ephedrine alkaloids-free Ephedra Herb extract (EFE) has been developed to eliminate the adverse effects caused by ephedrine alkaloid-induced sympathetic hyperactivation."( Ephedrine Alkaloids-Free Ephedra Herb Extract, EFE, Has No Adverse Effects Such as Excitation, Insomnia, and Arrhythmias.
Amakura, Y; Goda, Y; Hakamatsuka, T; Hanawa, T; Hyuga, M; Hyuga, S; Kobayashi, Y; Maruyama, T; Odaguchi, H; Oshima, N; Takahashi, J; Takemoto, H; Uchiyama, N; Yamashita, T, 2018
)
0.48
" Few studies exist quantifying adverse events during and after euthanasia."( An Objective Exploration of Euthanasia and Adverse Events.
Marchitelli, B, 2019
)
0.51
" We characterized the distribution of infant characteristics and evaluated the relationship between drug administration and any adverse event."( Comparative safety profile of chloral hydrate versus other sedatives for procedural sedation in hospitalized infants.
Balevic, S; Chu, V; Clark, R; Crenshaw, EG; Dallefeld, SH; Daniel, KR; Gilleskie, ML; Greenberg, RG; Kumar, KR; Smith, DS; Smith, PB; Zimmerman, KO, 2020
)
0.56
" Adverse events occurred in 41 (6%) infants."( Comparative safety profile of chloral hydrate versus other sedatives for procedural sedation in hospitalized infants.
Balevic, S; Chu, V; Clark, R; Crenshaw, EG; Dallefeld, SH; Daniel, KR; Gilleskie, ML; Greenberg, RG; Kumar, KR; Smith, DS; Smith, PB; Zimmerman, KO, 2020
)
0.56
"Administration of chloral hydrate to hospitalized infants undergoing minor procedures is associated with a lower risk for adverse events compared to other sedatives."( Comparative safety profile of chloral hydrate versus other sedatives for procedural sedation in hospitalized infants.
Balevic, S; Chu, V; Clark, R; Crenshaw, EG; Dallefeld, SH; Daniel, KR; Gilleskie, ML; Greenberg, RG; Kumar, KR; Smith, DS; Smith, PB; Zimmerman, KO, 2020
)
0.56

Pharmacokinetics

The values of the pharmacokinetic parameters for pentobarbital were determined in 18 cats, 12 of which were subjected to acute ischemic stroke by ligation of the left middle cerebral artery (LMCA) A slower plasma clearance rate and longer elimination half-life were observed in homozygous animals.

ExcerptReferenceRelevance
" The apparent elimination half-life was longer and the total voluem of distribution at steady state larger during halothane anesthesia."( Effect of different anesthetics on the pharmacokinetics and pharmacodynamics of pancuronium in the cat.
Agoston, S; Booij, LH; Crul, JF; Miller, RD; van der Pol, F, 1979
)
0.26
" The analysis of pharmacodynamic parameters has shown that this dose-dependent retardation of PB elimination is probably caused by an impairment of metabolic processes, resulting from disturbance of the circulatory system."( Dependence of pentobarbital kinetics upon the dose of the drug and its pharmacodynamic effects.
Danysz, A; Kozlowski, KH; Szaykowski, A,
)
0.49
" A slower plasma clearance rate and longer elimination half-life were observed in homozygous animals as well as increased overall volumes of pentobarbital distribution."( Effect of hyperbilirubinemia on the pharmacokinetics of pentobarbital in the rat.
Buice, RG, 1978
)
0.71
" In all cases, data on plasma levels were subjected to pharmacokinetic analyses."( Carbamazepine pharmacokinetics in young, adult and pregnant rats. Relation to pharmacological effects.
Assael, BM; Bossi, L; Garattini, S; Gerna, M; Gomeni, R; Morselli, PL, 1976
)
0.26
" A significant increase in elimination half-life (around 180 per cent), volume of distribution (130 per cent) and mean residence time (154 to 170 per cent) was observed in sheep infected by the parasite for four to 12 weeks."( Pharmacokinetics of ampicillin and pentobarbital in the course of subclinical fascioliasis in sheep.
Alvinerie, M; Galtier, P; Houin, G; Larrieu, G; Tufenkji, AE, 1991
)
0.56
" The results show that pharmacokinetic constants obtained in the anaesthetized animal may differ greatly from those in the conscious one."( The effect of pentobarbitone anaesthesia and hypothermia on the hepatic clearance of indocyanine green and S(-)-acenocoumarol in the rat.
Daemen, MJ; Smits, JF; Struyker Boudier, HA; Thijssen, HH; Vervoort-Peters, HT, 1986
)
0.27
" The use of urethane as an anesthetic in pharmacokinetic studies still persists, particularly in experiments of long duration."( Possible hemodynamic basis to urethane anesthesia-induced reductions in renal clearance.
Gumbleton, M; Nicholls, PJ; Taylor, G,
)
0.13
" However, this pharmacokinetic change could not fully explain the pharmacodynamic alternation."( Effect of chlorpromazine on the pharmacokinetics and pharmacodynamics of pentobarbital in rats.
Endoh, M; Hatanaka, T; Kakemi, M; Katayama, K; Koizumi, T; Sato, S, 1988
)
0.51
" Increases in pharmacologic effect that occur with aging may be caused by alterations in pharmacokinetic parameters or changes at the site of drug action."( Pharmacodynamics and pharmacokinetics of ethanol, diazepam and pentobarbital in young and aged rats.
Cooper, RL; Guthrie, S; Linnoila, M; Thurman, R, 1987
)
0.51
"03 L/kg and a terminal half-life of 19."( Pentobarbital pharmacokinetics in patients with severe head injury.
Blouin, RA; Porter, WH; Rapp, RP; Tibbs, PA; Wermeling, DP, 1987
)
1.72
" Mice exposed to 9800 micrograms O3/m3 (5 ppm) for 3 h had a 106% increase in the plasma half-life of pentobarbital; at 1960 micrograms O3/m3 (1 ppm) for 3 h, a 71% increase was observed."( Influence of ozone on pentobarbital pharmacokinetics in mice.
Gardner, DE; Graham, JA; Menzel, DB; Miller, FJ; Mole, ML,
)
0.66
" Pharmacokinetic parameters of volume of distribution at steady state (Vss), total body clearance (CL), and t1/2 for the patients with trauma were statistically compared with similar estimates reported for seven adult subjects without head injury."( Pharmacokinetics of high-dose pentobarbital in severe head trauma.
Bayliff, CD; Hardy, BG; Schwartz, ML, 1985
)
0.56
"Recovery characteristics of dispositional and pharmacodynamic tolerances produced by chronic Na-pentobarbital treatment were studied."( Recovery from dispositional and pharmacodynamic tolerance after chronic pentobarbital treatment.
Okamoto, M; Rao, SN; Reyes, J; Rifkind, AB, 1985
)
0.72
" Compared with pair-fed control rats, pentobarbital demonstrated a significantly prolonged clearance and elimination half-life without a change in volume of distribution."( Pharmacokinetics of pentobarbital, quinidine, lidocaine, and theophylline in the thermally injured rat.
DiGregorio, GJ; Fruncillo, RJ, 1984
)
0.86
" Pharmacokinetic and statistical analyses showed no significant effects of hyperbaria or hyperbaric hyperoxia on the total plasma clearance, volume of distribution or elimination half-life."( Pharmacokinetics of pentobarbital under hyperbaric and hyperbaric hyperoxic conditions in the dog.
Chaikin, BN; Fife, WP; Gross, DR; Kramer, WG; Medlock, C; Welch, DW, 1983
)
0.59
" After 7 days of continuous infusion of amino acid-glucose mixture via a gastric or jugular vein catheter, pharmacokinetic parameters were determined after 40 mg/kg of pentobarbital was given orally or into the portal or femoral vein."( Alterations in pentobarbital pharmacokinetics in response to parenteral and enteral alimentation in the rat.
Brooks, DA; Keller, FX; Knodell, RG; Kyner, WT; Spector, MH, 1980
)
0.81
" After pretreatment at 2 and 5 ppm for up to 10 days, all pentobarbital pharmacokinetic parameters obtained were comparable to control values."( Effects of short-term dietary exposure to polychlorinated biphenyls on pharmacokinetics of intravenous pentobarbital in rats.
Chu, CK; Stella, VJ, 1980
)
0.72
" Pentobarbital elimination half-life was not significantly different from control values."( High-dose pentobarbital pharmacokinetics in hypothermic brain-injured children.
Cupit, GC; Rocci, ML; Schaible, DH; Swedlow, DB, 1982
)
1.58
"The investigated method is based on an exact mathematical solution to the deconvolution problem of linear pharmacokinetic systems with a polyexponential impulse response."( Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response II: Numerical evaluation.
Pedersen, PV, 1980
)
0.26
"The values of the pharmacokinetic parameters for pentobarbital were determined in 18 cats, 12 of which were subjected to acute ischemic stroke by ligation of the left middle cerebral artery (LMCA)."( Alteration of pharmacokinetic parameters for pentobarbital by ischemic stroke and reversion to normal by dexamethasone treatment.
Black, KL; Jallad, NS; Wagner, JG; Weidler, DJ,
)
0.65
"0 mg/kg) and pharmacodynamic interactions of insecticide were studied with centrally acting drugs viz."( Pharmacodynamic interactions of cypermethrin and centrally acting drugs in mice.
Kanwar, RS; Varshneya, C, 1995
)
0.29
"A pharmacodynamic interactional study with omeprazole was undertaken in rats."( Pharmacodynamic interactions of omeprazole with CNS active drugs in rats.
Chakrabarti, A; Chandrashekhar, SM; Garg, SK, 1995
)
0.29
" Pharmacodynamic measures included subjective (euphoria, subject liking, sedation, and symptoms) and behavioral (signs and observed liking) responses."( Single-dose pharmacodynamics of diazepam and pentobarbital in substance abusers.
Jasinski, DR; Johnson, RE; Sullivan, JT, 1993
)
0.55
" Plasma concentrations of total phenytoin, unbound phenytoin, and the major metabolite of phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin, were measured, and pharmacokinetic variables obtained before and after barbiturate therapy were compared."( Effect of barbiturate therapy on phenytoin pharmacokinetics.
Abe, J; Asada, A; Fujimori, M; Kaji, A; Nishi, S; Oda, Y; Yoshida, N, 1993
)
0.29
" These results indicated that the pharmacokinetic and pharmacodynamic modeling of CPZ during the alteration of EEG may be complicated due to several pharmacokinetic and pharmacodynamic factors, such as an alteration of the free fraction of CPZ in the striatum, the formation of active metabolites, and two different intrinsic effects of CPZ on the EEG (one in an increase and the other in a decrease of the brain's electrical activity."( Pharmacokinetic and pharmacodynamic studies of centrally acting drugs in rat: effect of pentobarbital and chlorpromazine on electroencephalogram in rat.
Fukasawa, Y; Kakemi, M; Katayama, K; Koizumi, T; Koshiro, A; Sato, S, 1995
)
0.51
" laboratory and pharmacodynamic tests, as well as pharmacokinetic assays were performed prior to the operation as well as 10-12 days after the bile duct ligation."( Pharmacokinetics of lidocaine and its major metabolite- monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstruction.
Barcew-Wiszniewska, B; Droździk, M; Gawrońska-Szklarz, B; Gołdyn, U; Rózewicka, L; Skowron, J; Sulikowski, T; Wójcicki, J; Wójcicki, M,
)
0.13
" Therefore, it is appropriate to relate pharmacodynamic effects to racemic plasma concentrations of thiopental during IV infusion of racemic thiopental."( Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental.
Crankshaw, DP; McLeish, MJ; Morgan, DJ; Nguyen, KT; Stephens, DP, 1996
)
0.57
" However, the following main changes in N-acetylprocainamide (metabolite) pharmacokinetic parameters were found: 1) increase of the penetration rate constants between the compartments and mean residence time during propofol anesthesia 2) prolongation of the mean residence time during thiopental anesthesia 3) increase of mean residence time of N-acetylprocainamide during anesthesia with ketamine, pentobarbital or propofol."( The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part I. Procainamide and its active metabolite-N-acetylprocainamide.
Orszulak-Michalak, D,
)
0.3
"The influence of general anesthesia with thiopental (10 mg/kg), ketamine (4 mg/kg), propofol (10 mg/kg) or pentobarbital (20 mg/kg) on the N-acetylprocainamide (15 mg/kg) pharmacokinetic parameters was studied in rabbits."( The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part II. N-acetylprocainamide.
Orszulak-Michalak, D,
)
0.34
"The influence of selected general anesthetics: thiopental, propofol, ketamine and pentobarbital on the lidocaine pharmacokinetic parameters was studied in rabbits."( The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part IV. Lidocaine.
Orszulak-Michalak, D,
)
0.36
" Pharmacokinetic analysis revealed a modest, but significant (up to 40%) elevation in the area under the plasma concentration-time curve during 6 h of the drug administration, and a reduction in L-734,217 plasma clearance and volumes of distribution, in the anesthetized dogs."( Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734,217, in dogs.
Cook, JJ; Ellis, JD; Hand, EL; Holahan, MA; Prueksaritanont, T; Sitko, GR; Stranieri, MT, 1997
)
0.69
" Additional pharmacokinetic investigations are recommended to optimise pharmacological outcomes in patients with severe head injury."( Pharmacokinetic alterations after severe head injury. Clinical relevance.
Boucher, BA; Hanes, SD, 1998
)
0.3
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35
" Inclusion of such a pharmacokinetic compartment into the patch model introduced a slow kinetic component in the extracellular exchange time course, thereby providing recapitulation of divergent whole cell results."( Pentobarbital produces activation and block of {alpha}1{beta}2{gamma}2S GABAA receptors in rapidly perfused whole cells and membrane patches: divergent results can be explained by pharmacokinetics.
Burkat, PM; Gingrich, KJ; Roberts, WA, 2009
)
1.8
"To develop a means of euthanasia to support rapid time-course pharmacokinetic studies in mice, we compared retroorbital and intravenous lateral tail vein injection of ketamine-xylazine with regard to preparation time, utility, tissue distribution, and time to onset of euthanasia."( Euthanasia method for mice in rapid time-course pulmonary pharmacokinetic studies.
Chiang, PC; Heyde, BR; Hu, Y; Schoell, AR; Tung, DK; Weir, DE, 2009
)
0.35
" Serial pharmacokinetic blood samples were obtained."( Population pharmacokinetics of pentobarbital in neonates, infants, and children after open heart surgery.
Barrett, JS; Gastonguay, MR; Nicolson, SC; Zuppa, AF, 2011
)
0.66
" The purpose of this study was to evaluate pharmacokinetic (PK) parameters of vancomycin in patients with acute brain injury undergoing temperature modulation."( Vancomycin pharmacokinetic parameters in patients with acute brain injury undergoing controlled normothermia, therapeutic hypothermia, or pentobarbital infusion.
Jordan, JD; Morbitzer, KA; Rhoney, DH, 2015
)
0.62
"One- and two-compartment in silico pharmacokinetic models of midazolam and pentobarbital."( Pharmacokinetic Modeling of Optimized Midazolam and Pentobarbital Dosing Used in Treatment Protocols of Refractory Status Epilepticus.
Akhondi-Asl, A; Au, CC; LaRovere, K; Luchette, M; Tasker, RC, 2023
)
1.39
"Our in silico pharmacokinetic modeling of standard midazolam and pentobarbital dosing protocols for RSE suggests potential variables to optimize in future clinical studies."( Pharmacokinetic Modeling of Optimized Midazolam and Pentobarbital Dosing Used in Treatment Protocols of Refractory Status Epilepticus.
Akhondi-Asl, A; Au, CC; LaRovere, K; Luchette, M; Tasker, RC, 2023
)
1.4
" Prospective PK studies with pharmacodynamic endpoints, are imperative to optimise pentobarbital dosing in terms of safety and clinical efficacy in critically ill children."( A Population Pharmacokinetic Model of Pentobarbital for Children with Status Epilepticus and Severe Traumatic Brain Injury.
de Hoog, M; de Vries, JMP; de Winter, BCM; Ketharanathan, N; Koch, BCP; Lili, A; Wildschut, ED, 2023
)
1.41

Compound-Compound Interactions

Phencyclidine dose-effect curves for both rate and accuracy generally shifted progressively to the left as the dose of pentobarbital was increased. Dogs euthanatized with pentobarBital alone had significantly longer times than did dogs euthanated with lidocaine concentrations.

ExcerptReferenceRelevance
"Antitumor activity and lethality of cyclophosphamide alone and in combination with several drugs were investigated in male ddY mice."( [Drug interaction on antitumor drugs I. Antitumor activity of cyclophosphamide in mice consecutively administered aminopyrine, chlorpromazine, or morphine (author's transl)].
Saitoh, M; Sasaki, K; Takayanagi, G, 1979
)
0.26
" If pentobarbital was the CS and d-amphetamine or nicotine sulfate the US, then after about four drug-drug pairings the pentobarbital CS produced a higher heart rate (HR) than control conditions."( Drug-drug heart rate conditioning in rats: effective USs when pentobarbital is the CS.
Reilly, S; Revusky, S, 1992
)
1.08
" Comparison of backward and long-delayed controls in a drug-drug procedure that used a taste aversion test revealed that both forward and delayed pairings can produce attenuated aversions in relation to a backward group regardless of whether the unconditional stimulus is amphetamine (Experiment 1) or lithium chloride (Experiment 2)."( Methodological issues in drug-drug conditioning in rats: nonassociative factors in heart rate and avfail.
Biederman, GB; Davey, VA, 1991
)
0.28
"The effects of enoxacin, a new quinolone antibacterial agent, and its combination with 4-biphenylacetate (BPA), an active metabolite of the non-steroidal antiinflammatory agent fenbufen, were examined on population spikes induced by electrical stimulation of the stratum radiatum in the CA1 pyramidal cell layer in rat hippocampal slices."( Effects of enoxacin and its combination with 4-biphenylacetate, an active metabolite of fenbufen, on population spikes in rat hippocampal slices.
Hori, S; Ito, T; Kadokawa, T; Miura, Y; Miyahara, T; Shimada, J, 1991
)
0.28
" Nine healthy volunteers received three treatments: 1) 10 mg acenocoumarol in combination with cimetidine, 2) 10 mg acenocoumarol in combination with placebo, 3) 10 mg acenocoumarol after one week pretreatment with pentobarbitone."( Detection of drug interactions with single dose acenocoumarol: new screening method?
Cohen, AF; de Boer, A; Edelbroek, PM; Hoogkamer, JF; Kroon, C; Schoemaker, HC; van der Meer, EJ, 1990
)
0.28
"Guaifenesin was administered alone and in combination with ketamine or sodium pentobarbital to adult New Zealand white rabbits."( Guaifenesin alone or in combination with ketamine or sodium pentobarbital as an anesthetic in rabbits.
McCabe, K; Olson, ME; Walker, RL, 1987
)
0.74
" When phencyclidine was administered in combination with pentobarbital, the phencyclidine dose-effect curves for both rate and accuracy generally shifted progressively to the left as the dose of pentobarbital was increased."( Phencyclidine in combination with pentobarbital: supra-additive effects on complex operant behavior in patas monkeys.
Moerschbaecher, JM; Thompson, DM, 1982
)
0.79
" When phencyclidine was administered in combination with pentobarbital, the phencyclidine dose-effect curves for rate and accuracy shifted to the left as the dose of pentobarbital was increased."( Phencyclidine in combination with pentobarbital: supra-additive effects on complex operant behavior in pigeons.
Moerschbaecher, JM; Thompson, DM, 1982
)
0.79
" Dogs euthanatized with pentobarbital alone had significantly longer times than did dogs euthanatized with pentobarbital in combination with any of the lidocaine concentrations."( Comparison of pentobarbital alone and pentobarbital in combination with lidocaine for euthanasia of dogs.
Broadstone, R; Evans, AT; Hooks, TM; Johnston, SM; McNeil, JR; Stapleton, J, 1993
)
0.95

Bioavailability

The relative oral bioavailability of sodium pentobarbital is not influenced by dosing volume within the range tested. orally administered SP significantly decreases the propagation velocity and periodicity of the MMC in the small intestine.

ExcerptReferenceRelevance
" From these data and previously determined kinetic constants after intravenous administration, the absorption rates and bioavailability of pentobarbital from each dosage form were determined."( Pentobarbital absorption from capsules and suppositories in humans.
Chun, AH; Dittert, LW; Doluisio, JT; Smith, RB, 1978
)
1.9
" The results suggest that: 1) the relative oral bioavailability of sodium pentobarbital is not influenced by dosing volume within the range tested, 2) the various dosing volumes of SP tested moved through the gastrointestinal tract at an equal rate, and 3) orally administered SP significantly decreases the propagation velocity and periodicity of the MMC in the small intestine."( Oral absorption of sodium pentobarbital and effects on gastrointestinal function.
Curd-Sneed, CD; Stewart, JJ, 1989
)
0.81
"01) reduced the peak plasma concentration and oral bioavailability of SP."( Effects of activated charcoal and sorbitol on sodium pentobarbital absorption in the rat.
Bordelon, JG; Curd-Sneed, CD; Parks, KS; Stewart, JJ, 1987
)
0.52
" In animal studies, compound 6 (CCD 1042) is an orally active anticonvulsant, while the naturally occurring progesterone metabolites 1 and 2 are inactive when administered orally, suggesting that 3 beta-substitution slows metabolism of the 3-hydroxyl, resulting in orally bioavailable steroid modulators of the GABAA receptor."( Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor.
Acosta-Burruel, M; Alauddin, M; Bolger, MB; Gee, KW; Hawkinson, JE; Hogenkamp, DJ; Kimbrough, CL; Lan, NC; Tahir, SH; Upasani, RB; Whittemore, ER; Woodward, RM, 1997
)
0.3
" The anaesthesia increased the absolute bioavailability (F), the mean absorption time (MAT) and the hepatic recovery ratio (F(H)), but caused little change in the local absorption ratio into the portal system (Fa) and the total clearance (CL)."( Effect of pentobarbital anaesthesia on intestinal absorption and hepatic first-pass metabolism of oxacillin in rats, evaluated by portal-systemic concentration difference.
Nakagawa, T; Ueda, S; Yamaoka, K, 1999
)
0.71
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

The effects of pentobarbital on survival times of mice exposed to oxygen, 5 per cent, were studied over a large dosage range in normal mice and in mice made tolerant to the effect of barbiturates. Dosing can be aided by therapeutic drug.

ExcerptRelevanceReference
" Ouabain dosage needed to cause ventricular tachycardia was significantly higher than that of pentobarbital with all agents except fluroxene, as was the LD50."( The effect of enflurane, isoflurane, fluroxene, methoxyflurane and diethyl ether anesthesia on ouabain tolerance in the dog.
Albrecht, RF; Cairoli, VJ; El-Etr, AA; Grossman, RK; Ivankovich, AD; Miletich, DJ,
)
0.35
" Earlier dose-response studies in unanesthetized monkeys had shown that this dose of MIF stimulated motor activity; this dose of TRH had shown no stimulant effect, but a higher dose depressed activity."( Comparison of thyrotropin-releasing hormone with melanocyte-stimulating-hormone-release-inhibiting factor as pentobarbital antagonists in monkeys.
Crowley, TJ; Hydinger, M, 1977
)
0.47
" First, dose-response curves for each drug given alone were obtained."( Effects of combinations of phencyclidine and pentobarbital on schedule-controlled behavior in the squirrel monkey.
Balster, RL; Chait, LD, 1978
)
0.52
" After dosing with [14C]flurbiprofen, tissue levels of radioactivity in dog and baboon were similar to that in plasma."( The disposition and metabolism of flurbiprofen in several species including man.
Adams, SS; Crampton, EL; Marchant, B; Risdall, PC, 1978
)
0.26
" The dosage of the two drugs was determined on the basis of the monkeys' sensori-motor coordination which was assessed with a rating scale of reaching accuracy for food rewards."( Comparison of effects of pentobarbital and ethanol on the neuronal activity in the posterior parietal association cortex.
Hyvärinen, J; Laakso, M; Leinonen, L; Roine, R, 1979
)
0.56
" Chronic administration of p-chlorophenylalanine (p-CPA) in a dosage regimen which produced and maintained approximately 95% depletion of brain serotonin (5-HT) did not alter motor impairment after initial acute administration of ethanol or pentobarbital."( Effect of p-chlorophenylalanine on the acquisition of tolerance to ethanol and pentobarbital.
Frankel, D; Kalant, H; Khanna, JM; LeBlanc, AE, 1975
)
0.66
" Chronic administration of p-chlorophenylalanine (p-CPA), in a dosage regimen previously demonstrated to maintain extensive brain serotonin (5-HT) depletion, slowed down cross-tolerance development."( Effect of p-chlorophenylalanine on development of cross-tolerance between pentobarbital and ethanol.
Frankel, D; Kalant, H; Khanna, JM; LeBlanc, AE, 1977
)
0.49
" The derivative [1,3'-DCM2]TRH was still potent enough to block PB-induced PRL secretion at an intraventricular dosage of 50 ng."( Antagonism of pentobarbital-induced hormonal changes by TRH in rats.
Collu, R; Ducharme, JR; Ruisseau, PD; Taché, Y, 1977
)
0.62
"3 PB, tested at concentrations up to 80 muM, produced variable effects on the dose-response curve to GABA."( Reversal of the action of amino acid antagonists by barbiturates and other hypnotic drugs.
Bowery, NG; Dray, A, 1978
)
0.26
" The incidence of tracheal soiling was lower than that with other intravenous techniques and could be attributed to the use of the semisupine position or the baseline concept of narcotic dosage in the Jorgensen technique."( The efficacy of the laryngeal reflex in conscious sedation.
Allen, GD; Jorgensen, NB; Ricks, CS, 1977
)
0.26
" This difference was observed when thyrotropin was given intraperitoneally or intravenously and the slope of the dose-response curves to TRH showed a flattening of the curve of rats treated with ether and a steeper slope of response in animals anesthetized with pentobarbital."( Effects of ether and pentobarbital anesthesia on thyroid function in the rat.
Bray, GA; Ohtake, M, 1977
)
0.76
"A very easy, reliable and specific gas-chromatographic method for identification and dosage of 11 barbiturates in plasma is presented."( Routine identification and determination of 11 barbiturates in biological samples.
Faure, J; Feuerstein, C; Gavend, M; Vincent, F, 1979
)
0.26
"The effects of pentobarbital on survival times of mice exposed to oxygen, 5 per cent, were studied over a large dosage range in normal mice and in mice made tolerant to the effect of barbiturates."( Barbiturate protection in tolerant and nontolerant hypoxic mice: comparison with hypothermic protection.
Michenfelder, JD; Steen, PA, 1979
)
0.61
" Dose-response curves were obtained, and drug effects are described for position-specific and stimulus-specific behaviors."( Effects of sodium pentabarbital on matching behavior in the pigeon.
Berryman, R; Eckerman, DA; Lanson, RN, 1979
)
0.26
"0 g/kg) were examined in long-sleep (LS) and short-sleep (SS) mice that were genetically selected for differential sleep times induced by a hypnotic dosage of ethanol."( Electrophysiological responses to ethanol, pentobarbital, and nicotine in mice genetically selected for differential sensitivity to ethanol.
Barr, JE; Ryan, LJ; Sanders, B; Sharpless, SK, 1979
)
0.52
" At the highest (30 mg/kg) dosage of sodium pentobarbital, the spike frequency within the AD was decreased."( Hippocampal afterdischarges and their post-ictal sequelae in rats: a potential tool for assessment of CNS neurotoxicity.
Annau, Z; Dyer, RS; Eccles, CU; Swartzwelder, HS, 1979
)
0.52
" The animals were made physically dependent by 5 weeks of twice daily "maximally tolerable" sodium pentobarbital dosing intragastrically."( Evaluation of anticonvulsants in barbiturate withdrawal.
Boisse, NR; Okamoto, M; Rosenberg, HC, 1977
)
0.47
"After "chronically equivalent" barbital and pentobarbital dosing for 5 weeks, treatments were abruptly stopped and the animals were carefully observed for signs of barbiturate withdrawal."( Physical dependence to barbital compared to pentobarbital. III. Withdrawal characteristics.
Boisse, NR; Okamoto, M, 1978
)
0.78
" The rate of barbiturate elimination after chronically equivalent pentobarbital dosing was reduced by barbital substitution or by first-order pentobarbital dose reduction, with the result that withdrawal signs became mild and appeared later (3 days postdrug)."( Physical dependence to barbital compared to pentobarbital. IV. Influence of elimination kinetics.
Boisse, NR; Okamoto, M, 1978
)
0.76
" If a depression of brain metabolism is responsible for the previously reported protection of the brain from ischemic damage, these data suggest a substantial reduction of brain metabolic rate is achieved in the rat at a barbiturate dosage which may be therapeutically relevant in the human after acute brain ischemia."( Dose dependent reduction of glucose utilization by pentobarbital in rat brain.
Braun, LD; Cornford, EM; Crane, PD; Cremer, JE; Glass, JM; Oldendorf, WH,
)
0.38
" Three of the seven patients were given a dosage of medication and exceeding the manufacture's recommendation."( Toxic encephalopathy related to antihistamine-barbiturate antiemetic medication.
Patterson, JH; Schwartz, JF, 1978
)
0.26
" Pentobarbitone reversibly enhanced the conductance increase produced by GABA with a variable slowing of response kinetics, shifting GABA dose-response curves to the left."( Pentobarbitone pharmacology of mammalian central neurones grown in tissue culture.
Barker, JL; Ransom, BR, 1978
)
0.26
" From these data and previously determined kinetic constants after intravenous administration, the absorption rates and bioavailability of pentobarbital from each dosage form were determined."( Pentobarbital absorption from capsules and suppositories in humans.
Chun, AH; Dittert, LW; Doluisio, JT; Smith, RB, 1978
)
1.9
" Aging shifted the pentobarbital dose-response curve to the left in both control and lead-treated animals and flattened interresponse time (IRT) distributions."( Effects of lead on temporally-spaced responding in rats.
Dietz, DD; Grant, LD; Kimmel, CA; McMillan, DE, 1978
)
0.59
" While 3 to 100 mg/kg of TRH reduced pentobarbital sleeping time when administered prior to the barbiturate, a dose-response relationship to TRH could not be established."( Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs.
Breese, GR; Cooper, BR; Cott, JM; Lipton, MA; Plotnikoff, NP; Prange, AJ, 1975
)
0.77
" Principal features of the complex results include: double peaks in the time course of convulsion thresholds (Pc); an early peak and a shoulder in the time course of pressures reversing anesthesia (Pa); far steeper dose-response curves for Pa than for Pc; selectively greater anticonvulsant effect for phenobarbital than for the other barbiturates; and enhancement of Pa with simultaneous depression of Pc by reserpine in phenobarbital-pretreated mice."( Interaction of central nervous system effects of high pressures with barbiturates.
Beaver, RW; Brauer, RW; Lahser, S, 1977
)
0.26
" Analyes of dose-response relation in suppressing peak transient and steady-state conductances show that trichloroethylene interacts with receptor on a one-to-one stoichiometric basis."( Mode of action of trichloroethylene on squid axon membranes.
Kitz, RJ; Narahashi, T; Roberts, JD; Shrivastav, BB, 1976
)
0.26
"Cats were made physically dependent on sodium pentobarbital using the "maximally tolerable" dosing technique."( Electrophysiology of barbiturate withdrawal in the spinal cord.
Okamoto, M; Rosenberg, HC, 1976
)
0.51
" These permit the elaboration of dose-response lines for the substances in question, the calculation of median effective doses and the statistical analysis of differences in liver-damaging potency."( Quantitative aspects in the assessment of liver injury.
Plaa, GL, 1976
)
0.26
" Physical dependence was produced in 63 cats by 'maximally tolerable' dosing with sodium pentobarbital."( Withdrawal characteristics following chronic pentobarbital dosing.
Boisse, NR; Okamoto, M; Rosenberg, HC, 1976
)
0.74
" By utilizing the drugs discussed and titrating the dosage to the needs of the patient, intravenous sedation will last long enough to complete the selected periodontal surgical procedure."( Intravenous sedation of the periodontal surgical patient.
Ruggerio, AC, 1975
)
0.25
" A positive dose-response relationship was obtained only for pentobarbital; neither dose of diphenhydramine was significantly different from 60 mg of pentobarbital for any response variable."( Hypnotic efficacy of diphenhydramine, methapyrilene, and pentobarbital.
Brown, BW; Brown, CR; Forrest, WH; James, KE; Mahler, DL; Teutsch, G, 1975
)
0.74
"The method of "maximally tolerable" dosing technique for establishing a reproducible state of barbiturate dependence in cats was used for the study."( Tolerance characteristics produced during the maximally tolerable chronic pentobarbital dosing in the cat.
Boisse, NR; Okamoto, M; Rosenberg, HC, 1975
)
0.49
"A single dosage of sodium pentobarbital (5."( The growth-inhibiting effect of sodium pentobarbital on the body weight of the chick embryo.
Delphia, JM, 1975
)
0.82
" There was a significant difference in the slope of log dose-response curves; these curves were much steeper for pentobarbitone, droperidol and chlorpromazine than for nitrazepam, flunitrazepam, and diazepam."( [Action of central depressants on the nitrous oxide anesthesia (author's transl)].
Andics, A; Gogolák, G; Huck, S; Stumpf, C, 1975
)
0.25
" Linear dose effect curves relating discriminability (sessions to criterion) to dosage were obtained with all three drugs."( A comparison of the discriminable CNS effects of ketamine, phencyclidine and pentobarbital.
Overton, DA, 1975
)
0.48
"In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital."( The effects of ketamine and of Innovar anesthesia on digitalis tolerance in dogs.
El-Etr, AA; Ivankovich, AD; Janeczko, GF; Maronic, JP,
)
0.35
"001) when given in a dosage maintaining 3 or 4 of light sleep; the 2-h dosage had no such effect."( Effect of pentobarbital anaesthesia on luteinizing hormone levels in intact and ovariectomized ewes.
Benoit, HJ; Borth, R; Ellicott, AR; Strickler, RC; Woolever, CA, 1975
)
0.66
" It was found that both the curve for loss of righting reflex and the log dose-response curve, and hence the LD50, were significantly shifted to the right."( Biopharmaceutical factors influencing LD50. Part II: Particle size.
Ring, PE; Ritschel, WA; Siegel, EG, 1975
)
0.25
"Cats were made tolerant and physically dependent by twice daily equieffective anesthetic dosing with sodium pentobarbital intragastrically for 5 weeks."( Effect of chronic pentobarbital treatment on blood-cerebrospinal fluid kinetics.
Boisse, NR; Okamoto, M, 1975
)
0.8
"Using isolated rat aortic strips (AS) and portal veins (PV), it was found that all of the barbiturates studied (thiopental, secobarbital, pentobarbital, amobarbital, phenobarbital, and barbital): a) inhibit development of spontaneous mechanical activity (vasomotion) in AS and PV in concentrations used to induce surgical anesthesia or concentrations used for anticonvulsive therapy; b) dose-dependent attenuate contractions induced by epinephrine and potassium (K+); c) cause non-competitive displacement of the dose-response curves of these vasoactive compounds; d) attenuate calcium (Ca++)-induced contractions of K+-depolarized AS and PV; e) rapidly relax drug-induced, as well as Ca++-induced, contractions of AS and PV."( Barbiturates and aortic and venous smooth-muscle function.
Altura, BM; Altura, BT, 1975
)
0.46
" Simultaneous administration of imipramine and pentobarbital at the same dosage as in male rats is lethal for female rats without bile fistula within 30 min."( Biotransformation and biliary excretion of imipramine in rats under various experimental conditions.
Gigon, PL, 1975
)
0.51
" The results indicate that PTB can: a) inhibit development of spontaneous mechanical activity in these vessels in anesthetic concentrations; b) dose-dependently attenuate contractions induced by epinephrine, serotonin, and KC1; c) cause a noncompetitive type displacement of the dose response curves of these vasoactive agents; d) attenuate Ca2+- induced contractions of potassium-depolarized aortic strips and portal veins concomitant with a dose-dependent displacement of these dose-response curves to the right; and e) rapidly relax drug as well as Ca2+ -induced contractions of aortas and portal veins."( Pentobarbital and contraction of vascular smooth muscle.
Altura, BM; Altura, BT, 1975
)
1.7
" Dose-response curves were monophasic and linear over this range."( Propofol and barbiturate depression of spinal nociceptive neurotransmission.
Gibbs, LM; Jewett, BA; Kendig, JJ; Tarasiuk, A, 1992
)
0.28
" During dosing (10 mg kg-1 twice a day for 10 days) no effects on the electrocardiogram, monitored in conscious animals, were observed despite modest reductions (15-18%) in the maximum rate of depolarization of papillary muscle excised 1 or 6 h after completion of the dosing regime."( Antiarrhythmic, electrophysiological and haemodynamic effects of prolonged oral dosing with Org 7797 in the anaesthetized rat.
Delbressine, L; Harris, N; Kane, KA; Muir, AW; Winslow, E, 1992
)
0.28
"2% isoflurane for general surgical procedures; and for electrophysiological recordings in the eighth nerve we recommend barbiturate anesthesia of appropriate dosage in combination if possible with an opioid agent to provide additional analgesic action."( A comparison of anesthetic agents and their effects on the response properties of the peripheral auditory system.
Capranica, RR; Dodd, F, 1992
)
0.28
" Cross-tolerance was shown by shifts in dose-response curves for the LRR induced by n-propanol and t-butanol."( Effects of chronic treatment with ethanol on the development of cross-tolerance to other alcohols and pentobarbital.
Kalant, H; Khanna, JM; Lê, AD, 1992
)
0.5
" Ethoxyresorufin O-dealkylase (EROD) activity, an aryl hydrocarbon hydroxylase-type substrate, was significantly increased at all PCB concentrations, but the dose-response tended to plateau above 25 ppm."( Alkoxyresorufin metabolism in white-footed mice at relevant environmental concentrations of Aroclor 1254.
McKee, MJ; Simmons, GJ, 1992
)
0.28
" Chloral hydrate in dosages of 25 mg/kg to 100 mg/kg is the most common drug used for sedation; DPT, a combination of parenteral Demerol (meperidine), Phenergan (promethazine), and Thorazine (chlorpromazine), at a maximum dose of 2 mg/1 mg/1 mg/kg is the second; and pentobarbital in a dosage of 5 mg/kg to 7 mg/kg is the third."( Sedation of children for technical procedures: current standard of practice.
Alexander, ME; Bass, JW; Cook, BA; Nomizu, S, 1992
)
0.46
" In addition, the effect of ITI length on the dose-response curve for pentobarbital, phencyclidine, D-amphetamine, and cocaine were determined."( Titrating matching-to-sample performance: effects of drugs of abuse and intertrial interval.
Kimball, KA; Wenger, GR, 1992
)
0.52
" Functional changes in the GABAA receptors were assayed using the effects of potentiators (benzodiazepine, barbiturate) and antagonists (picrotoxin) on the muscimol control dose-response curves."( Functional changes in GABAA receptor stimulation during the oestrous cycle of the rat.
Lindgren, S; Meyerson, B; Westerling, P, 1991
)
0.28
" Comparison of the dose-response curves demonstrated a difference in the intensity of the stimulus effects."( The discriminative stimulus effects of diazepam in rats at two training doses.
Franklin, SR; Tang, AH, 1991
)
0.28
" Impairment of xenobiotic biotransformation was confirmed by elevated pentobarbital sleeping time in animals under the same CCl4 dosing regimen."( Enhanced neurotoxicity of 3,3'-iminodipropionitrile following carbon tetrachloride pretreatment in the rat.
Crofton, KM; Llorens, J, 1991
)
0.52
" The cross-reactive response of non-specific antibodies in polyclonal antisera was lowered at the suggested dosage for ethanol euthanasia."( Ethanol euthanasia and its effect on the binding of antibody generated against an immunogenic peptide construct.
Jones, GL; Lord, R; Spencer, L, 1991
)
0.28
"03-3 mg/kg did not produce changes in the midazolam dose-response curve for either unpunished or punished responding."( NMDA antagonists: lack of antipunishment effect in squirrel monkeys.
Balster, RL; Jortani, SA; Mansbach, RS; Willetts, J, 1991
)
0.28
" In order to use these effectively, the critical care nurse must be aware of the indications and controversies surrounding their use, the patho-physiologic conditions that impact on the disposition, and appropriate dosing and monitoring of these agents in the critical care setting."( Anticonvulsants: pharmacotherapeutic issues in the critically ill patient.
Dupuis, RE; Miranda-Massari, J, 1991
)
0.28
" Determination of the pentobarbital dose-response curve under the fixed-ratio component resulted in a steep curve characterized by responding on the saline lever at low doses and on the drug lever at higher doses."( Effects of schedule of reinforcement on a pentobarbital discrimination in rats.
McMillan, DE; Snodgrass, SH, 1991
)
0.86
" The present study examined whether pretreatment with a dose-response regimen of sodium pentobarbital would impact the stress-induced reduction in renal PBR."( Pentobarbital blocks the stress-induced decrease in [3H]Ro 5-4864 binding in rat kidney.
Drugan, RC; Holmes, PV; Stringer, AP, 1990
)
1.94
" Similarly, in pigeons trained to discriminate imipramine from saline, noneffective doses of CRF shifted the imipramine dose-response curve more than twofold to the left."( Interactions of corticotropin-releasing factor with antidepressant and anxiolytic drugs: behavioral studies with pigeons.
Barrett, JE; Zhang, L, 1990
)
0.28
" The dose-response relationships showed that the effect of enoxacin was 100 times potentiated in the presence of BPA (10(-5) M)."( Effects of enoxacin and its combination with 4-biphenylacetate, an active metabolite of fenbufen, on population spikes in rat hippocampal slices.
Hori, S; Ito, T; Kadokawa, T; Miura, Y; Miyahara, T; Shimada, J, 1991
)
0.28
" The dose-response curve with the dissociation constant 2 x 10(-3) mol/l was obtained."( [Taurine-activated currents in isolated neurons of the rat cerebellum].
Dashkin, AN; Garashchuk, OA; Valeev, AE, 1990
)
0.28
" Fischer 344 rats were separated into multiple groups and underwent two dose-response evaluations."( Cerebral radioprotection by pentobarbital: dose-response characteristics and association with GABA agonist activity.
Delaney, T; Friedman, R; Oldfield, EH; Olson, JJ; Orr, K, 1990
)
0.57
" Dose-response functions for generalization of morphine stimulus control were determined before, during, and after repeated treatment with selected doses of morphine."( Tolerance to morphine stimulus control: role of morphine maintenance dose.
Doty, MD; Lipinski, WJ; Sannerud, CA; Steigerwald, ES; Tetrick, LE; Young, AM, 1990
)
0.28
" The dose-response curve for GABA-induced Cl- conductance was sigmoidal with the GABA concentration producing a half-maximum response (4."( Interactions of gamma-aminobutyric acid (GABA), pentobarbital, and homopantothenic acid (HOPA) on internally perfused frog sensory neurons.
Akaike, N; Oomura, Y, 1985
)
0.52
" In the presence of DZP, the GABA dose-response curve shifted to the left without changing the maximum current, indicating that DZP modifies the interaction between GABA and its receptor rather than affecting directly the channel activation step."( Diazepam action on gamma-aminobutyric acid-activated chloride currents in internally perfused frog sensory neurons.
Akaike, N; Hattori, K; Oomura, Y, 1986
)
0.27
" The dose-response curve for NH4Cl was affected by simultaneous subcoma doses of VP and OA but not by PB."( Valproic acid induction of coma in rats: synergism with NH4+ and pentobarbital.
Lyftogt, C; Zieve, L, 1989
)
0.51
" The apparent KD = 417 nM and Bmax = 1083 fmol/mg of membrane protein were calculated using a computer program for dose-response curve fitting."( Further characterisation of the [35S]-TBPS binding site of the GABA receptor complex in locust (Schistocerca gregaria) ganglia membranes.
Brown, MC; Lunt, GC; Stapleton, A, 1989
)
0.28
" The response to a TRH challenge (10 micrograms/kg) was unaffected by the low dosage of SRIF14 infusion (0."( Somatostatin inhibition of thyrotropin-releasing hormone- and growth hormone-releasing factor-induced growth hormone secretion in young and adult anesthetized chickens.
Harvey, S; Scanes, CG, 1989
)
0.28
"Preference for pentobarbital was assessed in 12 normal healthy volunteers using a seven-session cumulative dosing choice procedure."( Assessing pentobarbital preference in normal volunteers using a cumulative dosing procedure.
de Wit, H; Johanson, CE; Pierri, J, 1989
)
1.03
"The effect of three dosage schedules on the expression of a withdrawal syndrome indicative of physical dependence on pentobarbital was determined in male Sprague-Dawley rats."( Intensity of the withdrawal syndrome varies with duration of pentobarbital administration.
Yutrzenka, GJ, 1989
)
0.73
" Their respective dose-response curves had a similar maximum but the slope of the curve for AMPA was consistently steeper than that for quisqualate."( The pharmacology of quisqualate and AMPA in the cerebral cortex of the rat in vitro.
Horne, AL; Simmonds, MA, 1989
)
0.28
"Theophylline concentrations in plasma and urine were determined during maintenance treatment in nine healthy volunteers during one dosage interval before and after 10 days of simultaneous treatment with pentobarbital (100 mg each night)."( Induction of theophylline metabolism by pentobarbital.
Billing, B; Dahlqvist, R; Koike, Y; Lind, M; Steiner, E; von Bahr, C, 1989
)
0.73
"An anaesthetic dose (40 mg/kg) of sodium pentobarbital (SP) was administered intragastrically to adult, fasted male rats at total dosing volumes of 1, 2, or 3 ml."( Oral absorption of sodium pentobarbital and effects on gastrointestinal function.
Curd-Sneed, CD; Stewart, JJ, 1989
)
0.84
" Antagonism of adenosine receptors with 1,3-dipropyl-8-p-sulfophenylxanthine shifted the dose-response curve to exogenous adenosine sixfold to the right yet did not influence vascular responses to PNS or NE in either SHR or WKY."( Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats.
Jackson, EK, 1987
)
0.27
" Pharmacologically specific results were obtained rapidly and reliably, using a cumulative dosing procedure."( A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats.
Koek, W; Ornstein, P; Woods, JH, 1987
)
0.27
"4,6,6-Trimethylcaprolactam antagonised GABAA receptor-mediated contractile responses in guinea-pig isolated ileum, displacing the GABA dose-response curve to the right in a non-parallel manner, and causing a depression of the maximum response."( Caprolactam-barbiturate interaction at the GABAA receptor complex in the guinea-pig intestine.
Kerr, DI; Ong, J; Prager, RH; Ward, DA, 1986
)
0.27
"The effects of a new fluorinated macrolide (P-0501A) on drug metabolizing enzymes of rat liver were compared with three erythromycins--the base, the stearate and the estolate--after 7 days of dosing (1."( Effects of a new fluorinated macrolide (P-0501A) and other erythromycins on drug metabolizing enzymes in rat liver.
Bartosek, I; Casacci, F; Corti, F; De Marchi, F; Guaitani, A; Pacei, E; Villa, P, 1986
)
0.27
"CGS-8216, a benzodiazepine antagonist, was administered to rats acutely dosed with diazepam, and to rats chronically dosed with diazepam or pentobarbital."( Benzodiazepine antagonist, CGS-8216, in diazepam- or pentobarbital-dependent and non-dependent rats.
Martin, WR; McNicholas, LF, 1986
)
0.72
" One week later, an initial dose-response curve for the motor impairment effect (moving belt test) of pentobarbital was obtained."( Effect of raphe lesions on the development of chronic tolerance to pentobarbital and cross-tolerance to ethanol.
Campanelli, C; Kalant, H; Khanna, JM; Lê, AD, 1987
)
0.72
" After responding had stabilized, dose-response curves were determined for R-(+)-pentobarbital, S-(-)-pentobarbital, R-(+)-secobarbital, and S-(-)-secobarbital in both species."( Chronic administration of S-(-)-pentobarbital in pigeons and rats: tolerance development.
Wenger, GR, 1988
)
0.78
"0 mg/kg AOAA significantly potentiated the effects of diazepam, as indicated by a significant shift to the left in the diazepam dose-response curve relative to diazepam alone."( Potentiation of the anticonflict effects of diazepam, but not pentobarbital and phenobarbital, by aminooxyacetic acid (AOAA).
Beshears, JF; Commissaris, RL; Halas, NA; McCloskey, TC, 1988
)
0.52
" Following a retrospective review of eight patients treated with a variety of barbiturates and dosing regimens, we established a specific protocol employing pentobarbital and evaluated it prospectively in six patients."( Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients.
Aminoff, MJ; Lowenstein, DH; Simon, RP, 1988
)
0.47
" After responding had stabilized, dose-response curves were determined in both groups for (S)-(-)-pentobarbital (0."( Discriminative stimulus properties of the isomers of pentobarbital and secobarbital in pigeons.
Wenger, GR, 1988
)
0.74
"The effect of chlorpromazine on the duration of loss of righting reflex (LRR, sleeping time) of pentobarbital and vice versa in a various dosage ranges were studied in rats."( The pharmacodynamic and pharmacokinetic interaction of pentobarbital and chlorpromazine in rats.
Hatanaka, T; Kakemi, M; Katayama, K; Koizumi, T; Negishi, S, 1988
)
0.74
"Fischer 344 (F344), Lewis (LEW), spontaneously hypertensive (SHR) and Wistar Kyoto (WKY) rats were chronically fed food containing pentobarbital on an escalating drug dosage schedule over a period of 47 days."( Genetic differences in the development of physical dependence on pentobarbital in four inbred strains of rats.
George, FR; Koike, Y; Meisch, RA; Suzuki, T; Yanaura, S, 1987
)
0.72
" Dosing rates were adjusted based on the patient's clinical status."( Pentobarbital pharmacokinetics in patients with severe head injury.
Blouin, RA; Porter, WH; Rapp, RP; Tibbs, PA; Wermeling, DP, 1987
)
1.72
" A solution of 5% guaifenesin in 5% dextrose given intravenously at a dosage of 200 mg/kg, abolished the pedal, palpebral and corneal reflexes for up to 15 minutes with little influence on cardiopulmonary function."( Guaifenesin alone or in combination with ketamine or sodium pentobarbital as an anesthetic in rabbits.
McCabe, K; Olson, ME; Walker, RL, 1987
)
0.52
" Nicardipine in a dosage of 1 mg/kg effectively attenuated the liberation of FFAs, particularly that of arachidonic acid which is known as the precursor of prostaglandins, thromboxanes, and leukotrienes."( Ca2+ antagonist and protection of the brain against ischemia. Effects of nicardipine on free fatty acid liberation in the ischemic brain in rats.
Handa, J; Kidooka, M; Matsuda, M, 1987
)
0.27
" Cumulative dosing of methamphetamine and morphine increased response rates without marked changes in avoidance rates in the shuttle avoidance response."( [Effects of psychotropic drugs by the cumulative-dosing procedure on lever-press and shuttle discrete avoidance responses in mice].
Furusawa, K; Kuribara, H; Tadokoro, S, 1987
)
0.27
" Dose-response curves were determined separately for each isomer of pentobarbital (1-17."( Stereoselective behavioral effects of the isomers of pentobarbital and secobarbital in the pigeon.
Cunny, HC; Donald, JM; Wenger, GR, 1986
)
0.76
" Dose-response functions for stimulus control and response rate were determined for pentobarbital alone and in combination with selected doses of d-amphetamine or ethanol."( Differential modification of pentobarbital stimulus control by d-amphetamine and ethanol.
Kline, FS; Young, AM, 1986
)
0.79
" As clearance values showed marked inter- and intraindividual variability, it is necessary to monitor pentobarbital plasma levels frequently to adapt the dosage to the changes in clearance."( Monitoring of pentobarbital plasma levels in critical care patients suffering from increased intracranial pressure.
Dennhardt, R; Heinemeyer, G; Roots, I, 1986
)
0.85
", their approximate preferred Ta when dosed with sodium pentobarbital)."( Effect of sodium pentobarbital on behavioral thermoregulation in rats and mice.
Gordon, CJ; Long, MD; Strek, KS, 1986
)
0.86
" The course of concentration under maintenance dosage was extremely variable, mainly due to interindividual and intraindividual variations in clearance."( [Thiopental kinetics in high-dose use].
Jensen, U; Murr, R; Peter, K; Schmiedeck, P; Taeger, K, 1986
)
0.27
" The effective dosage of the drugs were 20-40 mg/kg in pentobarbital, 10-20 mg/kg in diazepam, and 12."( [Treatable ischemic neuronal damage in the gerbil hippocampus].
Kirino, T; Sano, K; Tamura, A; Tomukai, N, 1986
)
0.52
" Dose-response curves were obtained and plotted against control animals (n = 10)."( Grip strength test and infrared thermometry as non-invasive methods to complement acute toxicity data in mice.
Nordmann, H, 1985
)
0.27
" A dose-response curve to NE, ANG II, and lysine vasopressin was also performed."( Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia.
Brunner, HR; Nussberger, J; Schaller, MD; Waeber, B, 1985
)
0.27
" Furthermore, with increasing ethanol pretreatment the shift in dose-response curves for the loss-of-righting reflex was affected more than the shift in dose-response curves for lethality."( Ethanol drug interaction with chlordiazepoxide and pentobarbital.
Aaronson, LM; Okamoto, M; Rao, SN; Walewski, JL, 1985
)
0.52
" using a cumulative dosing regimen in conscious (6, 24 and 60 micrograms/kg) and anesthetized (6 and 60 micrograms/kg) rats."( Effects of nimodipine on cerebral blood flow in conscious rat.
Flaim, SF; Kanda, K, 1986
)
0.27
" Tolerance to ethanol or pentobarbital was characterized by a parallel shift of the dose-response curve to the right."( Tolerance to and cross-tolerance among ethanol, pentobarbital and chlordiazepoxide.
Grossi, F; Kalant, H; Khanna, JM; Lê, AD, 1986
)
0.83
" The degree of drug tolerance was assessed by determining cumulative dose-response functions for morphine before, during and after chronic administration."( Modification of morphine tolerance by behavioral variables.
Sannerud, CA; Young, AM, 1986
)
0.27
" At a dosage of 60 micrograms/kg, strychnine caused convulsions in all control animals, but in none pretreated with CdCl2."( Augmented depression and reduced excitability of the central nervous system (CNS) by cadmium in the rat.
Hall, CE; Hungerford, S; Nasseth, D, 1985
)
0.27
" Yohimbine injection at postpentobarbital dosing minute 50 reversed the resumed xylazine-induced bradycardia and relieved other signs of respiratory depression associated with xylazine-pentobarbital anesthesia."( Xylazine-pentobarbital anesthesia in dogs and its antagonism by yohimbine.
Hsu, WH, 1985
)
0.98
" Drug concentrations in plasma were found to be threefold higher in anesthetized animals, whereas drug levels in perilymph were the same in both groups at similar dosing rates."( Effect of pentobarbital anesthesia on amikacin concentrations in plasma and perilymph and evaluation of multiple sampling in perilymph of guinea pigs.
Beaubien, AR; Cauchy, MJ; Desjardins-Giasson, S, 1985
)
0.67
" This case report demonstrates remarkable alterations in the CLT as a result of high doses of pentobarbital, necessitating the need for substantial dosage adjustments of theophylline."( Influence of high-dose pentobarbital on theophylline pharmacokinetics: a case report.
Bauer, LA; Blouin, RA; Gibson, GA; Rapp, RP; Tibbs, PA, 1985
)
0.8
" All doses of PDG which affected respiration uniformly produced initial apnea, whose duration, in any given animal and trial session, exhibited a consistent dose-response relationship."( The respiratory response to stimulation of juxta-pulmonary capillary receptors in the non-anesthetized cat.
Ginzel, KH; Lucas, EA, 1985
)
0.27
" A large contribution to total body clearance was not evident, and dosage adjustment would have been unwarranted."( Hemodialysis clearance of pentobarbital during continuous infusion.
Bell, R; Blouin, R; Porter, W; Record, K; Wermeling, D, 1985
)
0.57
"3 A second cannabis extract (II) with a different ratio of cannabinoids (also administered in dosage equivalent to 10 mg Delta(9)-THC/kg) failed to affect pentobarbitone anaesthesia in mice."( Interaction of cannabis and general anaesthetic agents in mice.
Chesher, GB; Jackson, DM; Starmer, GA, 1974
)
0.25
" No dose-response relationship could be found for either adrenaline or noradrenaline released by angiotensin, or for noradrenaline released by bradykinin."( The effects of bradykinin, angiotensin and acetylcholine on the bovine adrenal medulla.
Comline, RS; Silver, M; Sinclair, DG, 1968
)
0.25
" This has been applied to the analysis of some of these drugs in plasma taken from patients after therapeutic dosage and over-dosage."( A rapid micro-method for the screening and measurement of barbiturates and related compounds in plasma by gas-liquid chromatography.
Flanagan, RJ; Withers, G, 1972
)
0.25
" The dosage of the hormone, the time of the neonatal period, and differences in the animal strain, are considered influencing factors on this effect."( Some aspects of the mechanisms involved in steroid-induced sterility.
Arai, Y, 1972
)
0.25
" However, actinomycin D, at a dosage of 250 mug/mouse in vivo and 10 mug/ml in vitro produces breakdown of labeled RNA, thus confirming earlier observations that the drug is not a suitable tool for RNA kinetics determinations."( Pulse labeling of RNA of mammalian cells.
Baserga, R; Berman, S; Rovera, G, 1970
)
0.25
" PB shifted the dose-response curve for GABA in the presence of bicuculline methochloride to the left without altering the slope or the dose ratio, and not only displaced the dose-response curve for GABA in the presence of picrotoxinin but also restored the slope and the maximum response towards that of the control GABA-induced response."( Potentiation of GABAA-receptor-mediated responses by barbiturates in the guinea-pig ileum.
Kerr, DI; Ong, J, 1984
)
0.27
" Following discrimination training subjects were tested for generalization to five dosage levels (5, 10, 15, 20, 25 mg/kg) of phenobarbital."( Assessment of drug state dimensionality via drug-drug training and stimulus generalization testing.
Akins, FR; Gouvier, WD; Trapold, MA, 1984
)
0.27
" Dose-response data were obtained for barbiturate concentrations ranging from 1 microM to 3 mM."( Effects of barbiturates on inhibitory and excitatory responses to applied neurotransmitters in Aplysia.
Cote, IL; Wilson, WA, 1980
)
0.26
" Dose-response curves were constructed for amino-oxyacetic acid and gamma-acetylenic GABA."( Blockade of methamphetamine-induced depression of tyrosine hydroxylase by GABA transaminase inhibitors.
Gibb, JW; Hotchkiss, A, 1980
)
0.26
" In order to further study the mechanism of brain stimulation punishment, dose-response curves of two minor tranquilizers, chlordiazepoxide and pentobarbital, of two tryptamine antagonists, methysergide and cyproheptadine as well as of amphetamine on lever-pressing behavior of rats maintained by water reinforcement and punished by DPAG stimulation were determined."( Effect of minor tranquilizers, tryptamine antagonists and amphetamine on behavior punished by brain stimulation.
de Aguiar, JC; Graeff, FG; Morato de Carvalho, S, 1981
)
0.46
"A simple model system for the behavioral actions of benzodiazepines is analyzed for its dose-response predictiveness, using several benzodiazepines, and for its pharmacological specificity, using other non-anxiolytic classes of psychoactive drugs."( Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines.
Crawley, JN, 1981
)
0.26
" accommodation was enhanced) at the anesthetic dosage level."( A comparison of the effects of pentobarbital and diphenylhydantoin on the GABA sensitivity and excitability of adult sensory ganglion cells.
Connors, BW, 1981
)
0.55
" When washed P2 membranes were subjected to high-frequency homogenization, the biphasic dose-response relationship for pentobarbitone was markedly shifted to the right."( Dual action of pentobarbitone on GABA binding: role of binding site integrity.
Johnston, GA; Willow, M, 1981
)
0.26
" Picrotoxin, and agent which blocks the chloride ionophore of GABA-receptor complex, exhibited a parallel dose-response curve with respect to muscimol."( Acute and chronic effects of pentobarbital in relation to postsynaptic GABA receptors: a study with muscimol.
Ho, IK; Nabeshima, T; Sivam, SP, 1982
)
0.56
") shifted the dose-response curve for both responses to the right more for the beta-EP than for DADL."( Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
Cheng, SS; Fujimoto, JM; Tseng, LF, 1983
)
0.27
" These actions of barbiturates were not accompanied by changes in the apparent dissociation constant of the GABA-current dose-response curve or the reversal potential for GABA currents."( Effect of barbiturates on the GABA receptor of cat primary afferent neurones.
Higashi, H; Nishi, S, 1982
)
0.26
" In animals initially anesthetized with pentobarbital, delta-9-THC over a wide dosage range produced only an enhancement of the reflex, whereas in methohexital-treated animals only depression was elicited."( Influence of different barbiturate anesthetics on delta-9-tetrahydrocannabinol effects on spinal monosynaptic reflexes.
Karler, R; Turkanis, SA, 1983
)
0.53
" Pretreatment with the convulsant bemegride antagonized the pentobarbital transfer but not the chlordiazepoxide cue, whereas the specific benzodiazepine antagonist RO15-1788 decreased the chlordiazepoxide cue in a dose-response manner without attenuating the pentobarbital transfer."( Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat.
Schechter, MD, 1984
)
0.74
"1-80 micrograms/kg) and in both cases the dose-response relationship was biphasic."( Comparative stimulation of growth hormone secretion in anaesthetized chickens by human pancreatic growth hormone-releasing factor (hpGRF) and thyrotrophin-releasing hormone (TRH).
Harvey, S; Scanes, CG, 1984
)
0.27
" The total ouabain dosage required for ventricular tachycardia was recorded, and the ouabain concentrations in the arterial plasma and in the myocardium were determined by liquid scintillation counting."( Lack of protection against ouabain cardiotoxicity after chronic ablation of the area postrema in cats.
Borison, HL; Riancho, JA; Thron, CD, 1984
)
0.27
" Further, the dosage per unit of surface area in the URT may be 5000-6000 times that of the LRT."( The comparative absorption and excretion of chemical vapors by the upper, lower, and intact respiratory tract of rats.
McKenna, MJ; Stott, WT, 1984
)
0.27
" The pooled mean dosage level of pentobarbital required for anesthesia was 12."( Meperidine-acepromazine-pentobarbital anesthesia in cats: reversal by 4-aminopyridine and yohimbine.
Booth, NH; Hatch, RC; Zahner, JM, 1984
)
0.86
"l-1--the drug concentration was approximated theoretically) was assessed from the dose-response curve."( Effect of pentobarbital on neurones in the reticular formation of the brain stem: ionophoretic study in the rat.
Hricovíni, M; Pavlásek, J, 1984
)
0.67
" Graphic representation of the dose-response relationships suggested that these drugs possess different sites and/or mechanisms of action."( Ethanol and pentobarbital have different behavioral effects in the rat.
Schechter, MD, 1984
)
0.65
" Subsequently, increasing doses of phencyclidine, barbital, amobarbital, phenobarbital, methaqualone, methyprylon, diazepam, oxazepam, and d-amphetamine were substituted for the training dose of phencyclidine, using a cumulative dosing procedure."( Effects of barbiturates and other sedative hypnotics in pigeons trained to discriminate phencyclidine from saline.
McMillan, DE; Wenger, GR, 1983
)
0.27
" This dosage produced a minimal increase in heart rate and reduced the PR interval."( The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog.
Farah, A; Kabela, E; Mendez, R; Pastelin, G, 1983
)
0.27
" Required dosage of pentobarbital, arousal and walk times (measured from injection of antagonists), respiratory rate, and heart rate were measured."( Comparison of five preanesthetic medicaments in pentobarbital-anesthetized dogs: antagonism by 4-aminopyridine, yohimbine, and naloxone.
Booth, NH; Clark, JD; Hatch, RC; Kitzman, JV, 1983
)
0.85
" Male EC and IC rats did not differ in the CD50 (50% convulsion dosage by log probit analysis) following injection of a range of metrazol doses (20 to 35 mg/kg, IP) when they were kept in a quiet dimly lighted room."( Differential rearing affects responsiveness of rats to depressant and convulsant drugs.
Conlee, JW; Greenough, WT; Juraska, JM, 1983
)
0.27
" Animals were treated with Na pentobarbital according to the "maximally tolerable" dosing schedule described previously, twice a day for 35 days, and abruptly withdrawn."( Effects of individual variations in drug elimination kinetics for production of pentobarbital physical dependence.
Hinman, DJ; Okamoto, M, 1983
)
0.78
") administered in combination with naloxone and picrotoxin shifted dose-response curves for both naloxone and picrotoxin to the right."( Comparison of the effects of naloxone and picrotoxin on schedule-controlled responding in the pigeon: possible GABA-antagonistic effects of naloxone.
Carter, RB; Leander, JD, 1984
)
0.27
" The degree of the first-pass effect and the influence of the polychlorinated biphenyl exposure were quantitated by comparing the areas under the plasma concentration--time curves after oral and intravenous dosing in control and treated animals."( Effect of short-term exposure to polychlorinated biphenyls on first-pass metabolism of pentobarbital in rats.
Chu, CK; Stella, VJ, 1980
)
0.48
" It is concluded that TRH can modify only the acute responses of PB in naive and PB-tolerant mice, however, in the dosage regimen used it does not affect the processes involved in the genesis of the tolerant state."( The effects of thyrotropin releasing hormone on pentobarbital tolerance.
Bhargava, HN, 1981
)
0.52
" The pentobarbital response was chosen in tests with phenobarbital, dimethylphenobarbital, or methsuximide in the anticonvulsant dosage range."( Discriminative, disinhibitory, and depressant effects of several anticonvulsants.
Alvin, JD; Barry, H; Krimmer, EC, 1982
)
0.78
" Based on the time of 50% recovery (RR performance recovering to 90 seconds or more), both chronic treatments resulted in a significant shift of the dose-response curves for PB, MQ and DZ to the right."( Tolerance and cross-tolerance to central nervous system depressants after chronic pentobarbital or chronic methaqualone administration.
Commissaris, RL; Rech, RH, 1983
)
0.49
"3 mg/kg) or prazosin in high dosage (0."( Bronchopulmonary effects of clonidine on the bronchomotor responses of the guinea-pig.
Advenier, C; Floch, A; Mallard, B, 1983
)
0.27
" Although the dose-response functions for rates of responding and intake under both schedules were similar, the local pattern of responding under the second-order schedule was under the control of both the brief stimulus presentations as well as drug delivery."( Behavior maintained under fixed-interval and second-order schedules of cocaine or pentobarbital in rhesus monkeys.
Johanson, CE, 1982
)
0.49
" The rats were injected weekly IP with sodium pentobarbital; each rat's dosage increased 10 mg/kg per week to the dose that was lethal."( Duration of response to pentobarbital of female vs male albino and pigmented rats.
Bolam, JM; Westenberg, IS, 1982
)
0.83
" When the external Na and Ca concentrations were adjusted so that V max of Na- and Ca-spikes were similar, prior to drug addition, the PB dose-response curves for Na- and Ca-spikes overlapped."( Effect of pentobarbital on Na and Ca action potentials in an invertebrate neuron.
Blaustein, MP; Goldring, JM, 1982
)
0.67
" Dose-response curves for the effect of pentobarbital on respiratory activity of each cell type were constructed with the two substrates."( Differential effect of pentobarbital on chick neurons and astrocytes grown in culture.
Roth-Schechter, BF; Tholey, G, 1982
)
0.84
"Adult proestrous rats were subjected to either electrochemical or electrical stimulation of the medial preoptic area after ovulation-blocking dosage with either pentobarbital (PTBL), morphine, chlorpromazine, or atropine."( Similarity of luteinizing hormone surges induced by medial preoptic stimulation in female rats blocked with pentobarbital, morphine, chlorpromazine, or atropine.
Everett, JW; Tyrey, L, 1982
)
0.67
" Maximal response rates for NPA were about 1/2 of that of A, NMA and NEA, and the dose-response curve was shifted to the right of these compounds by about 4 times."( Structure-activity relationships among some d-N-alkylated amphetamines.
Johanson, CE; Shybut, G; Woolverton, WL, 1980
)
0.26
" We observed a striking reduction in the size of infarction in the animals treated with thiopental at moderate and prolonged dosage levels."( The controlled delivery of thiopental and delayed cerebral revascularization.
Agdeppa, D; Dujovny, M; Lipton, SD; Mazel, M; Nelson, D; Segel, R; Yonas, H, 1981
)
0.26
" When graphically represented, the dose-response curves were shown to be parallel suggesting a common site and/or mechanism of action."( Effect of fenfluramine and nicotine upon a stimulant-depressant continuum.
Schechter, MD, 1981
)
0.26
" Multiple factors determined the nature of this wastage, including dosage of Nembutal [sodium 5-ethyl-5-(1-methyl butal) barbiturate], route of its administration, degree of resulting respiratory depression, and ultimately a pH imbalance (below 7) in the mother."( Sodium pentobarbital-induced mutations in the hamster.
Ingalls, TH; Ito, T,
)
0.59
" Inhalation of pure oxygen shifted the dose-response curve of the respiratory effect towards the right."( Long-lasting hyperventilation induced by almitrine: evidence for a specific effect on carotid and thoracic chemoreceptors.
Laubie, M; Schmitt, H, 1980
)
0.26
"Cumulative dose-response curves have been widely used in many areas of pharmacology."( Cumulative dose-response curves in behavioral pharmacology.
Wenger, GR, 1980
)
0.26
" In alpha-chloralose-anesthetized rats, tachyphylaxis to pericardial administration of 1 microgram BK occurred at 5 and 15, but not at 30 min dosing intervals."( Use of an indwelling catheter for examining cardiovascular responses to pericardial administration of bradykinin in rat.
Gebhart, GF; Gutterman, DD; McDermott, DA; Meller, ST, 1995
)
0.29
"The dose-response relationship of commercially available preparations of methohexital, pentobarbital, phenobarbital, and thiopental and their respective drug-free solutions on granulocyte function was investigated to evaluate whether suppression of neutrophil chemiluminescence is mediated by the barbiturates themselves or by their drug-free solutions."( Do barbiturates impair zymosan-induced granulocyte function?
Birkhahn, A; Buhl, R; Mirow, N; Schneider, M; Weiss, M; Wernet, P, 1994
)
0.51
"The dose-response effects of the four barbiturates on granulocyte function were tested by zymosan-induced neutrophil chemiluminescence and, in addition, in a cell-free chemiluminescence system."( Do barbiturates impair zymosan-induced granulocyte function?
Birkhahn, A; Buhl, R; Mirow, N; Schneider, M; Weiss, M; Wernet, P, 1994
)
0.29
" For this purpose, complete nicotine dose-response curves were made for mean arterial pressure and heart rate."( Cardiovascular effects of different schedules of nicotine administration on spinal rats: influence of pentobarbital.
Cruz, SL; Fernández-Guasti, A; Villarreal, JE, 1994
)
0.5
"The dose-response relationship of four commercially available barbiturates (methohexitone, pentobarbitone, phenobarbitone and thiopentone) and of their drug-free solutions on the production of oxygen radicals by neutrophils were tested by N-formylmethionyl-leucyl-phenylalanine (FMLP)-induced granulocyte chemiluminescence and in a cell-free chemiluminescence system."( Do barbiturates and their solutions suppress FMLP-induced neutrophil chemiluminescence?
Birkhahn, A; Buhl, R; Mirow, N; Schneider, M; Weiss, M; Wernet, P, 1994
)
0.29
" In the physical dependence test, nefiracetam and codeine phosphate were administered to rats mixed with food for 43 days in a gradually increasing dosage schedule, followed by feeding a drug-free normal diet to detect signs of withdrawal."( Drug dependence study of the new cognition-enhancing agent nefiracetam in rats.
Akiyama, Y; Fujikawa, K; Takayama, S, 1994
)
0.29
" Pentobarbitone had similar voltage-independent blocking effects on sodium channels from eel electroplax and human brain, as demonstrated by similar dose-response curves (IC50 = 613 mumol litre-1)."( Molecular actions of pentobarbitone on sodium channels in lipid bilayers: role of channel structure.
Duch, DS; Rehberg, B; Urban, BW; Wang, J; Wartenberg, HC, 1994
)
0.29
" Cumulative dose-response curves for chlordiazepoxide were obtained before and during chronic chlordiazepoxide administration and during chronic saline administration."( Tolerance to the behavioral effects of chlordiazepoxide: pharmacological and biochemical selectivity.
Alastra, AJ; Cohen, C; Goldberg, SR; Marley, RJ; Sannerud, CA; Serdikoff, SL, 1993
)
0.29
" The dosage schedule for propofol was 2 mg/kg (with supplemental 1 mg/kg boluses) followed by continuous infusion of 6 mg/kg per hour."( Intravenous sedation for MR imaging of the brain and spine in children: pentobarbital versus propofol.
Bloomfield, EL; Caplin, A; Ebrahim, ZY; Goske, MJ; Hayden, J; Masaryk, TJ; Obuchowski, NA; Ross, JS; Ruggieri, PM; Schubert, A, 1993
)
0.52
" Dose-response curves for pentobarbital given alone and in combination with morphine were determined (by probit analysis) separately for each of the pressure levels."( Pentobarbital-morphine anesthetic interactions in terms of intensity of noxious stimulation required for arousal.
Bradley, EL; Brown, PT; Kissin, I; Stanski, DR, 1993
)
2.03
" Acute and long-term dosing increased both rearing and locomotion frequencies observed in an open field."( Behavioral effects of acute and long-term administration of catnip (Nepeta cataria) in mice.
Bernardi, MM; Gorniak, SL; Massoco, CO; Silva, MR; Spinosa, MS, 1995
)
0.29
" Under this dosing condition, autonomic blockade by phentolamine, propranolol, or atropine still evoked discernible but differential reductions in the SAP and HR spectral components."( Auto- and cross-spectral analysis of cardiovascular fluctuations during pentobarbital anesthesia in the rat.
Chan, SH; Kuo, TB; Yang, CC, 1996
)
0.53
" The addition of methoxyflurane significantly potentiated the anaesthetic and analgesic properties of the high dosage ketamine-xylazine combination."( Evaluation of anaesthetic regimens in guineapigs.
Crenshaw, D; Hinson, A; Radde, GR; Toth, LA, 1996
)
0.29
" Further, we examined whether an ovulation-blocking dosage of pentobarbital sodium (PB) would affect the NAL-induced Fos expression."( Fos expression by naloxone in LHRH neurons of the mediobasal hypothalamus and effects of pentobarbital sodium in the proestrous rat.
Funabashi, T; Jinnai, K; Kimura, F, 1997
)
0.76
" Under this simple schedule, dose-response curves were determined for diazepam, morphine, pentobarbital, and phencyclidine."( Behavior of rats under fixed consecutive number schedules: effects of drugs of abuse.
Hardin, JL; McMillan, DE; Snodgrass, SH, 1997
)
0.52
" Dose-response curves for M and P were obtained under these conditions and also when every 30th peck during the FI was punished by shock."( Punishment alters the discriminative stimulus effects of midazolam.
Barrett, JE; Roden, MM; Tatham, TA, 1997
)
0.3
"High performance liquid chromatography (HPLC) is used to determine impurities in pentobarbital (I) and pentobarbital sodium (II) and to determine the strength of the drug substance and dosage forms."( Determination of pentobarbital and pentobarbital sodium in bulk drug substance and dosage forms by high-performance liquid chromatography.
Elrod, L; Morley, JA, 1997
)
0.86
" This rightward shift of the morphine dose-response curve was reversed by the intrathecal administration of either the CCKA receptor antagonist, lorglumide, or the CCKB receptor antagonist, PD135, 158."( Pentobarbital antagonism of morphine analgesia mediated by spinal cholecystokinin.
Fujimoto, JM; Lin, W; Rady, JJ, 1998
)
1.74
" Within each of the three dosage periods, the duration of sleep and extent of reduction in body temperature of the rats decreased with time."( Effects of pentobarbital on the expression of GABAA receptor beta 1 mRNA in the hippocampus: differential responses of CA1 and CA3.
Lee, YP; Yin, HS, 1998
)
0.69
" Next, the drug discrimination dose-response curves were redetermined."( A history of postponing shock does not appear to alter the discriminative stimulus effects of cocaine.
Hasling, TA; Tatham, TA, 1998
)
0.3
" Muscarine shifted the GABA dose-response curve to the left, with the GABA EC50 decreased from 45 +/- 2 to 13 +/- 2 microM."( Enhancement of GABA-activated current by muscarine in rat dorsal root ganglion neurons.
Hu, HZ; Li, ZW; Shao, M, 1999
)
0.3
"01 mg/kg), which by itself decreased arterial pressure only in the Hiroshima rats, the dose-response curve for [Arg8]-vasopressin was much more greatly shifted to the right in the control rats."( Effects of exogenous [Arg8]-vasopressin on borderline-hypertensive Hiroshima rats.
Kumazaki, T; Ozono, R; Teranishi, Y; Tsuru, H, 1999
)
0.3
" To provide loading and maintenance dosing for patients with hepatic induction secondary to concurrent anticonvulsants."( Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus.
Chicella, MF; Dalton, JT; Eades, SK; Hovinga, CA; Phelps, SJ; Rose, DF, 1999
)
0.3
" In test sessions preceded by doses of pentobarbital, chlordiazepoxide, or ethanol, pigeons switched from responding on the saline-biased key at low doses to responding on the pentobarbital-biased key at higher doses (the dose-response curve was quantal)."( Drug discrimination under a concurrent fixed-ratio fixed-ratio schedule.
Li, M; McMillan, DE, 1999
)
0.57
" When the pentobarbital dose-response curve was determined under the concurrent VI 50-s VI 50-s schedule, responding was fairly evenly distributed on both levers for most rats."( Drug discrimination in rats under concurrent variable-interval variable-interval schedules.
Hardwick, WC; McMillan, DE, 2000
)
0.71
" Together with the fact that this dosage of PB blocks the surge of LH secretion in rats in proestrus, the concept of the existence of separate neuronal mechanisms responsible for the surge and pulsatile secretion of LH are supported."( Pentobarbital stimulates the activity of the GnRH pulse generator interacting with opioid neurons in rats in proestrus.
Funabashi, T; Jinnai, K; Kimura, F; Sano, A; Shinohara, K, 2000
)
1.75
" Despite these effects of training history on drug-discrimination responding, during the first minute of the session, the dose-response curves for pentobarbital, chlordiazepoxide, ethanol, phencyclidine and methamphetamine were similar in both groups of pigeons."( Effects of training history on drug discrimination under concurrent fixed-interval schedules.
Li, M; McMillan, DE, 1999
)
0.5
" This effect was confirmed when pretreatment of the jejunum preparation with LS produced a dose-dependent shift of the Ca(2+) dose-response curve to the right, similar to the effect of verapamil, a standard calcium channel blocker."( Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L.
Aziz, N; Gilani, AH; Herzig, JW; Jabeen, Q; Khan, MA; Shaheen, F; Siddiqui, BS, 2000
)
0.31
" The three subjects with the highest relative sedative dosage even displayed an inverted (negative) BOLD contrast signal."( Effect of pentobarbital on visual processing in man.
Ekatodramis, D; Hennig, J; Huisman, T; Joeri, P; Loenneker, T; Marcar, VL; Martin, E; Thiel, T, 2000
)
0.71
" Dose-response determinations of ethanol, pentobarbital, midazolam, muscimol and morphine were made under the training condition of 30 min pretreatment interval."( Characterization of the discriminative stimulus effects of GABA(A) receptor ligands in Macaca fascicularis monkeys under different ethanol training conditions.
Azarov, A; Grant, KA; Green-Jordan, K; Szeliga, KT; Waters, CA, 2000
)
0.57
" Panadiplon pretreatment resulted in leftward shifts in the pentobarbital dose-response function but predominantly rightward shifts of the triazolam dose-response function."( Discriminative stimulus effects of panadiplon (U-78875), a partial agonist at the benzodiazepine site, in pentobarbital-trained rhesus monkeys.
Rowlett, JK; Woolverton, WL, 2001
)
0.77
" When ethanol (10% v/v) was added to the sucrose reinforcer, MK-801 and pentobarbital dose-response curves were shifted significantly to the left."( The discriminative stimulus properties of self-administered ethanol are mediated by GABA(A) and NMDA receptors in rats.
Bratt, AM; Camarini, R; Cox, AA; Hodge, CW; Iller, K; Kelley, SP; Mehmert, KK; Nannini, MA; Olive, MF, 2001
)
0.54
" When responding was maintained under the FR schedule, the dose-response curves for drugs that generalized to the training drugs were quantal in shape, while under the FI schedule, the dose-response curves for drugs that generalized to the training drugs were graded."( Schedule control of quantal and graded dose-effect curves in a drug-drug-saline discrimination.
Hardwick, WC; Li, M; McMillan, DE, 2001
)
0.31
" Under the FR schedule, pentobarbital dose-response curves were usually quantal, whereas under the FI schedule the pentobarbital dose-response curves usually were graded."( Discrimination of pentobarbital doses and drug mixtures under fixed-ratio and fixed-interval reinforcement schedules.
Hardwick, WC; Li, M; McMillan, DE, 2001
)
0.95
" The potential for serious complications of pentobarbital therapy among neonates highlights the need for careful dosing in this age group."( Neurologic outcomes of pediatric epileptic patients with pentobarbital coma.
Kim, JS; Kim, SJ; Lee, DY, 2001
)
0.82
" However, infusions of either 3alpha-5alpha-P or pentobarbital in the hippocampus failed to substitute for ethanol and produced inverted U-shaped dose-response curves."( Allopregnanolone and pentobarbital infused into the nucleus accumbens substitute for the discriminative stimulus effects of ethanol.
Hodge, CW; Kelley, SP; Mehmert, KK; Nannini, MA; Olive, MF, 2001
)
0.88
" The in vivo administration of the thiol drugs, at dosage regimes available in literature, was able to markedly prevent the BZ prolongation effect on the sleeping time."( Prevention of benznidazole-induced prolonging effect on the pentobarbital sleeping time of rats using different thiol-containing compounds.
Bernacchi, AS; Castro, JA; Montalto de Mecca, M,
)
0.37
"7), indicating that one binding step of pentobarbital at alpha(1)beta(2)gamma(2S) GABA(A) receptor channels can describe the experimental dose-response relation."( Kinetic analysis of the agonistic and blocking properties of pentobarbital on recombinant rat alpha(1)beta(2)gamma(2S) GABA(A) receptor channels.
Bufler, J; Dengler, R; Krampfl, K; Wolfes, H, 2002
)
0.82
" Thus, drug discrimination can be established under concurrent VR VR schedules, but the shapes of drug-discrimination dose-response curves under concurrent VR VR schedules more closely resemble those seen under interval schedules than those seen under fixed-ratio schedules."( Drug discrimination under concurrent variable-ratio variable-ratio schedules.
Hardwick, WC; Li, M; McMillan, DE, 2002
)
0.31
" When dose-response curves were redetermined with a cumulative-dosing procedure, the same pattern of generalization occurred as under single-dose procedures."( Four-choice drug discrimination in pigeons.
Li, M; McMillan, DE, 2001
)
0.31
"The combination of meperidine, atropine, and pentobarbital is a safe and effective premedication for cardiac catheterization when administered in standard dosage based upon body weight."( Oral meperidine, atropine, and pentobarbital for pediatric conscious sedation.
Porter, AG; Vincent, RN; Winn, CW,
)
0.68
" FFTs of raw signals were generated at baseline (predose) and after intraperitoneal dosing of the rats with atropine (30 min postdose; 6 mg/kg), caffeine (90 and 150 min postdose; 30 mg/kg), ketamine (15 and 30 min postdose; 50 mg/kg), and pentobarbarbital (60 and 90 min postdose; 40 mg/kg)."( Development of a quantitative method for evaluation of the electroencephalogram of rats by using radiotelemetry.
Cain, C; Fitzgerald, AL; Juneau, P; Southwick, K, 2003
)
0.32
", respectively; significant inhibition associated with 10 mg/kg of TAK-427 was still observed 24 h after dosing in guinea pigs."( Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
Ashida, Y; Fukuda, S; Fukui, H; Gyoten, M; Kawano, Y; Midoro, K; Nagaya, H; Yamasaki, M, 2003
)
0.32
" After responding stabilized, dose-response curves were determined for other drugs."( Retention of sequential drug discriminations under fixed-interval schedules for long time periods without training.
Li, M; McMillan, DE, 2003
)
0.32
" Dosing of the analgesics and sedatives was based on a neonatal sedation score for ventilated infants."( Endogenous distress in ventilated full-term newborns with acute respiratory failure.
Aretz, S; Licht, C; Roth, B, 2004
)
0.32
"A total of 61 patients were enrolled in the study (27 etomidate group, 34 pentobarbital group) at 2 different dosing regimens for etomidate."( Etomidate versus pentobarbital for sedation of children for head and neck CT imaging.
Hunter, J; Kienstra, AJ; Macias, CG; Morriss, MC; Sasan, F; Ward, MA, 2004
)
0.89
"At the dosing used in this study, pentobarbital is superior to etomidate when comparing success rates for sedation."( Etomidate versus pentobarbital for sedation of children for head and neck CT imaging.
Hunter, J; Kienstra, AJ; Macias, CG; Morriss, MC; Sasan, F; Ward, MA, 2004
)
0.94
"To develop an oral vaccine carrying glutamate carboxypeptidase II (GCP II) and to explore whether it can affect the dosage of pentobarbiturate."( [Development of oral vaccine carrying GCPII gene and its role in reducing the dosage of pentobarbital in rat: a primitive research].
Dou, WC; Kong, YG; Li, GL; Li, SF; Tian, SQ; Wang, RZ; Wang, X; Yao, Y; Zhang, B; Zhang, ZX, 2004
)
0.55
" The dosage of pentobarbiturate used in experimental group was 36."( [Development of oral vaccine carrying GCPII gene and its role in reducing the dosage of pentobarbital in rat: a primitive research].
Dou, WC; Kong, YG; Li, GL; Li, SF; Tian, SQ; Wang, RZ; Wang, X; Yao, Y; Zhang, B; Zhang, ZX, 2004
)
0.55
"An oral vaccine carrying GCP II gene has been developed that activates the immune response of rat to produce GCP II antibodies and lower the dosage of pentobarbiturate needed."( [Development of oral vaccine carrying GCPII gene and its role in reducing the dosage of pentobarbital in rat: a primitive research].
Dou, WC; Kong, YG; Li, GL; Li, SF; Tian, SQ; Wang, RZ; Wang, X; Yao, Y; Zhang, B; Zhang, ZX, 2004
)
0.55
"81 mcg/kg), but no significant difference was found in pentobarbital dosing between groups 1 and 2, respectively (4."( Moderate sedation for MRI in young children with autism.
Garrett, NT; Hazlett, HC; Piven, J; Ross, AK; Wilkerson, C, 2005
)
0.58
"Orodispersible tablets, usually prepared using freeze-drying method, are becoming a popular drug formulation for patients who have difficulties swallowing solid dosage forms."( The physical characteristics of lyophilized tablets containing a model drug in different chemical forms and concentrations.
Klunder, M; Płaczek, M; Sznitowska, M,
)
0.13
" In subsequent testing, dose-response curves were determined for the individual drugs, for a wide range of dose combinations of the training drugs, and for two drugs to which the pigeons had not been exposed previously (pseudoephedrine and nicotine)."( Effects of amphetamine-CNS depressant combinations and of other CNS stimulants in four-choice drug discriminations.
Li, M; McMillan, DE; Wessinger, WD, 2005
)
0.33
" Dose-response curves with increasing GTN infusions after 24 h GTN-patch pretreatment revealed a significant attenuation of the MAP decrease compared to placebo."( Nitroglycerin-patch induced tolerance is associated with reduced ability of nitroglycerin to increase exhaled nitric oxide.
Agvald, P; Gustafsson, LE; Hammar, L, 2005
)
0.33
" Combined administration of sodium pentobarbital and 846 mixture resulted in good anesthetic effect with reduced anesthetic dosage and minimal side effect on the viscera (the liver, kidney and heart, etc)."( [Establishment of a pig model of chronic ally enhanced external counterpulsation].
Chen, XL; Fang, DQ; He, XH; Liang, LG; Ma, H; Qian, YT; Zhan, CY; Zhang, Y; Zheng, ZS, 2006
)
0.61
" When dosed at 10mg/kg, beta-acids increased, in the elevated plus maze, open arm entries reducing in parallel those in closed arms."( Evidence that the beta-acids fraction of hops reduces central GABAergic neurotransmission.
Avallone, R; Baraldi, M; Brusiani, F; Losi, G; Puia, G; Rivasi, M; Zanoli, P; Zavatti, M, 2007
)
0.34
" In order to determine the proper timing of assessments and to identify the most active extract, a 100mg/kg dosage of hexane, ethyl acetate and methanol crude extracts were tested on SPP after 15, 30 and 60min of the administration."( Pharmacological evaluation of the anxiolytic and sedative effects of Tilia americana L. var. mexicana in mice.
Aguirre-Hernández, E; González-Trujano, ME; Martínez, AL; Moreno, J; Soto-Hernández, M; Vibrans, H, 2007
)
0.34
" 68 children under 8 years of age were given rectal pentobarbital for ABR testing at a dosage of about 5 mg/kg."( [Rectal pentobarbital sedation for children undergoing auditory brainstem response testing].
Baculard, F; Cousin, J; Eslami, A; François, M; Rieutord, A; Van Den Abbeele, T, 2007
)
1.02
" In the drug discrimination procedure, Ro-60-0175 was not generalised with nicotine but shifted the nicotine dose-response curve to the right in a dose-related manner."( The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination.
Naylor, CG; Quarta, D; Stolerman, IP, 2007
)
0.34
" Sanjoinine A also increased sleeping rate and sleeping time when administered combined with pentobarbital at a sub-hypnotic dosage and showed synergistic effects with muscimol in potentiating sleeping onset and enhancing sleeping time induced by pentobarbital."( Sanjoinine A isolated from Zizyphi Spinosi Semen augments pentobarbital-induced sleeping behaviors through the modification of GABA-ergic systems.
Eun, JS; Han, H; Hong, JT; Kim, HC; Ma, Y; Oh, KW, 2007
)
0.8
"The independent activity test and the hypnotic synergism test by sub-threshold hypnotic dosage of pentobarbital were employed to evaluate the central pharmacological effect of the extract-compounds, and the minimal neurotoxicity was evaluated by the rotorod test."( [Hypnotic effect of Chinese materia medica Cynanchum chinese in mice].
Peng, JZ; Peng, XD; Wang, R; Yan, QS; Yang, WD, 2007
)
0.56
" It also significantly increased the falling asleep rate and duration of sleeping time at a sub-hypnotic dosage of pentobarbital (28 mg/kg)."( Cyclopeptide alkaloid fraction from Zizyphi Spinosi Semen enhances pentobarbital-induced sleeping behaviors.
Han, H; Hong, JT; Kim, YB; Ma, Y; Nam, SY; Oh, KW; Yun, YP, 2008
)
0.79
" The magnitude of the shift to the right in the cocaine dose-response function was directly related to PB dose."( Self-administration of cocaine-pentobarbital mixtures by rhesus monkeys.
Wang, Z; Woolverton, WL, 2009
)
0.64
" However, the whole-cell GABA dose-response and the single-channel effective opening rate curves were shifted to higher GABA concentrations, suggesting that the concatemeric receptors have a lower affinity to GABA."( Activation and modulation of concatemeric GABA-A receptors expressed in human embryonic kidney cells.
Akk, G; Bracamontes, J; Li, P; Steinbach, JH, 2009
)
0.35
" MELA also increased sleep rate and sleep time in the combined administration with pentobarbital at the sub-hypnotic dosage and showed synergic effects with muscimol in potentiating sleep onset and enhancing sleep time induced by pentobarbital."( Methanol extract of Longanae Arillus augments pentobarbital-induced sleep behaviors through the modification of GABAergic systems.
Eun, JS; Hong, JT; Kim, YB; Lee, MK; Ma, H; Ma, Y; Nam, SY; Oh, KW, 2009
)
0.84
", 5-min pretreatment) shifted the ethanol, PB, and midazolam dose-response functions rightward in a vast majority of monkeys tested (15/15, 16/17, and 11/12, respectively)."( Antagonism of the ethanol-like discriminative stimulus effects of ethanol, pentobarbital, and midazolam in cynomolgus monkeys reveals involvement of specific GABA(A) receptor subtypes.
Grant, KA; Helms, CM; Rogers, LS, 2009
)
0.58
" Torcetrapib was dosed orally (3, 30 mg/kg) and intravenously (0."( Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogs.
Campbell, TJ; Cox, BF; Gintant, GA; Kempf-Grote, AJ; King, AJ; Marsh, KC; Mittelstadt, SW; Nelson, RA; Polakowski, JS; Preusser, LC, 2009
)
0.6
"5 to 5 g/L) have been recommended, but few reports describe dose-response testing, the time to loss of consciousness, or the reliability of euthanasia."( Evaluation and refinement of euthanasia methods for Xenopus laevis.
Green, SL; McClure, DE; Torreilles, SL, 2009
)
0.35
"The purpose of this retrospective medical chart review was to describe dosing regimens and outcomes in children who received continuous pentobarbital therapy for refractory status epilepticus."( Continuous infusion pentobarbital for refractory status epilepticus in children.
Barberio, M; Dobyns, EL; Kaufman, J; Knupp, K; Reiter, PD, 2012
)
0.91
" The results also demonstrate the presence of interactions between allosteric activators and potentiators, raising a possibility of effects on dosage requirements or changes in side effects."( The benzodiazepine diazepam potentiates responses of α1β2γ2L γ-aminobutyric acid type A receptors activated by either γ-aminobutyric acid or allosteric agonists.
Akk, G; Eaton, MM; Li, P; Steinbach, JH, 2013
)
0.39
" Dosing of pentobarbital can be aided by therapeutic drug monitoring (TDM)."( Therapeutic Drug Monitoring of Pentobarbital: Experience at an Academic Medical Center.
Drees, D; Ehlers, A; Humble, RM; Krasowski, MD; Kulhavy, J; Morris, C; Pakalniskis, BL, 2015
)
1.09
" Chart review included patient diagnosis, indication for pentobarbital therapy, recent or concomitant medication with other barbiturates, patient disposition, organ donation, pentobarbital dosing changes, and neurosurgical procedures."( Therapeutic Drug Monitoring of Pentobarbital: Experience at an Academic Medical Center.
Drees, D; Ehlers, A; Humble, RM; Krasowski, MD; Kulhavy, J; Morris, C; Pakalniskis, BL, 2015
)
0.95
" An electroencephalographic endpoint was used in over half of the patients; higher midazolam dosing was used with a burst suppression endpoint."( Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital.
Abend, NS; Arya, R; Brenton, JN; Carpenter, JL; Chapman, KE; Gaillard, WD; Glauser, TA; Goldstein, J; Goodkin, HP; Helseth, AR; Jackson, MC; Kapur, K; Loddenkemper, T; Mikati, MA; Peariso, K; Sánchez Fernández, I; Tasker, RC; Wainwright, MS; Wilfong, AA; Williams, K, 2016
)
0.65
" On completion of dosing after 4 weeks, alteration in sleep induction and recovery times was noted and compared."( Effect of calcium hypochlorite and chloramine on blood biochemistry and sodium pentobarbital induced sleeping time in mice.
Altaf, I; Ashraf, M; Fatima, G; Ishaq, S; Rasheed, MA; Rehmat, S, 2016
)
0.66
" Current guidelines for refractory status epilepticus (RSE) recommend initiating a continuous intravenous (CIV) anesthetic over bolus dosing with a different AED."( Continuous Infusion Antiepileptic Medications for Refractory Status Epilepticus: A Review for Nurses.
Jones, GM; Marler, J; Samarin, M; Wiss, AL,
)
0.13
" In the Rotarod test, Kabuchii did not affect the motor performance, even at the highest dosage tested (3 mg/cage), whereas diazepam decreased it dose- dependently."( Enhancement of Pentobarbital-induced Sleep by the Vaporized Essential Oil of Citrus keraji var. kabuchii and its Characteristic Component, y-Terpinene.
Fua, Z; Kinjo, Y; Kobayashi, Y; Shimizu, E; Takemoto, H, 2016
)
0.79
"To evaluate the effects of pentobarbital dosages on lower urinary tract function and to define an appropriate dosage of sodium pentobarbital that would be suitable for urodynamic studies in which recovery from anesthesia and long term survive were needed for subsequent experiment."( Verification and Defined Dosage of Sodium Pentobarbital for a Urodynamic Study in the Possibility of Survival Experiments in Female Rat.
Abulikim, K; Cao, P; Du, GH; Tan, HB; Xu, SF, 2020
)
1.12
"This study confirmed significant dose-dependent effects of pentobarbital on lower urinary tract function and 32 mg/kg pentobarbital as an appropriate dosage for recovery urodynamic testing, which enable the achievement of expected essential micturition under satisfactory anesthesia in female rats."( Verification and Defined Dosage of Sodium Pentobarbital for a Urodynamic Study in the Possibility of Survival Experiments in Female Rat.
Abulikim, K; Cao, P; Du, GH; Tan, HB; Xu, SF, 2020
)
1.07
" We also provide dosing information for pentobarbital administration."( Pentobarbital Coma Use in a Pregnant Patient With Refractory Intracranial Hypertension: A Case Report.
Barnett, R; Dehne, K; Pajer, H; Patel, D; Quinsey, C; Sasaki-Adams, D,
)
1.84
"Our in silico pharmacokinetic modeling of standard midazolam and pentobarbital dosing protocols for RSE suggests potential variables to optimize in future clinical studies."( Pharmacokinetic Modeling of Optimized Midazolam and Pentobarbital Dosing Used in Treatment Protocols of Refractory Status Epilepticus.
Akhondi-Asl, A; Au, CC; LaRovere, K; Luchette, M; Tasker, RC, 2023
)
1.4
"To investigate pentobarbital PK in SE and sTBI patients admitted to the paediatric intensive care unit (PICU) with population-based PK (PopPK) modelling and dosing simulations."( A Population Pharmacokinetic Model of Pentobarbital for Children with Status Epilepticus and Severe Traumatic Brain Injury.
de Hoog, M; de Vries, JMP; de Winter, BCM; Ketharanathan, N; Koch, BCP; Lili, A; Wildschut, ED, 2023
)
1.53
" Dosing simulations formulated adjusted dosing advice in patients with elevated creatinine and/or CRP."( A Population Pharmacokinetic Model of Pentobarbital for Children with Status Epilepticus and Severe Traumatic Brain Injury.
de Hoog, M; de Vries, JMP; de Winter, BCM; Ketharanathan, N; Koch, BCP; Lili, A; Wildschut, ED, 2023
)
1.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
GABAA receptor agonistA GABA receptor agonist specific for GABAA receptors, ligand-gated ion channels (also known as ionotropic receptors).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
barbituratesMembers of the class of pyrimidones consisting of pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) and its derivatives. Largest group of the synthetic sedative/hypnotics, sharing a characteristic six-membered ring structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (29)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency39.81070.177814.390939.8107AID2147
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency31.62280.011212.4002100.0000AID1030
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency31.62280.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)IC50 (µMol)299.00000.00032.63119.0000AID1207759
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)IC50 (µMol)1,000.00000.00011.14948.0000AID698848
Gamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)IC50 (µMol)88.00000.00011.30188.0000AID698849
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)IC50 (µMol)299.00000.00032.59559.0000AID1207759
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)IC50 (µMol)11,465.91300.00091.901410.0000AID240820; AID576612
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)IC50 (µMol)299.00000.00032.63119.0000AID1207759
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)IC50 (µMol)299.00000.00032.25459.6000AID1207759
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)EC50 (µMol)50.00000.00141.957810.0000AID240319
Gamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)EC50 (µMol)50.00000.01201.17515.2000AID240319
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)EC50 (µMol)50.00000.00141.776810.0000AID240319
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (77)

Processvia Protein(s)Taxonomy
visual perceptionVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
detection of light stimulus involved in visual perceptionVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
calcium ion import across plasma membraneVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
post-embryonic developmentGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
adult behaviorGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
signal transductionGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
roof of mouth developmentGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
chemical synaptic transmissionGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
regulation of membrane potentialGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
regulation of presynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chemical synaptic transmissionGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
inner ear receptor cell developmentGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
innervationGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cochlea developmentGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
regulation of membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
calcium ion transportVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
sensory perception of soundVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
positive regulation of adenylate cyclase activityVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
positive regulation of calcium ion transportVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
regulation of atrial cardiac muscle cell membrane repolarizationVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
calcium ion importVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
calcium ion transmembrane transportVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
cardiac muscle cell action potential involved in contractionVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
membrane depolarization during cardiac muscle cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
membrane depolarization during SA node cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
regulation of heart rate by cardiac conductionVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
regulation of potassium ion transmembrane transporter activityVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
regulation of potassium ion transmembrane transportVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
calcium ion import across plasma membraneVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
regulation of heart rate by cardiac conductionPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of heart rate by hormonePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of membrane potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
potassium ion homeostasisPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
cardiac muscle contractionPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of membrane repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of ventricular cardiac muscle cell membrane repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
cellular response to xenobiotic stimulusPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
potassium ion transmembrane transportPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
ventricular cardiac muscle cell action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane depolarization during action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane repolarization during action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane repolarization during cardiac muscle cell action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of heart rate by cardiac conductionPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
potassium ion export across plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane repolarization during ventricular cardiac muscle cell action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of potassium ion transmembrane transportPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
negative regulation of potassium ion transmembrane transportPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
positive regulation of potassium ion transmembrane transportPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
negative regulation of potassium ion export across plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
potassium ion import across plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
skeletal system developmentVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
extraocular skeletal muscle developmentVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
calcium ion transportVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
muscle contractionVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
striated muscle contractionVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
endoplasmic reticulum organizationVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
myoblast fusionVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
neuromuscular junction developmentVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
skeletal muscle adaptationVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
positive regulation of muscle contractionVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
skeletal muscle fiber developmentVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
release of sequestered calcium ion into cytosolVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
calcium ion transmembrane transportVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
cellular response to caffeineVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
calcium ion import across plasma membraneVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
immune system developmentVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
heart developmentVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ionVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
embryonic forelimb morphogenesisVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
camera-type eye developmentVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
positive regulation of adenylate cyclase activityVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
positive regulation of muscle contractionVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
calcium ion transport into cytosolVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
cardiac conductionVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
calcium ion transmembrane transport via high voltage-gated calcium channelVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
calcium ion transmembrane transportVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
cardiac muscle cell action potential involved in contractionVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
membrane depolarization during cardiac muscle cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
membrane depolarization during AV node cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
cell communication by electrical coupling involved in cardiac conductionVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
regulation of heart rate by cardiac conductionVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
regulation of ventricular cardiac muscle cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
membrane depolarization during atrial cardiac muscle cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
calcium ion import across plasma membraneVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (32)

Processvia Protein(s)Taxonomy
voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
metal ion bindingVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
high voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
GABA receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
protein bindingGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
identical protein bindingGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
protein bindingGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
GABA receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
high voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
protein bindingVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
ankyrin bindingVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
metal ion bindingVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
alpha-actinin bindingVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
voltage-gated calcium channel activity involved in cardiac muscle cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
voltage-gated calcium channel activity involved SA node cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
transcription cis-regulatory region bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
inward rectifier potassium channel activityPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated potassium channel activityPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
delayed rectifier potassium channel activityPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
protein bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
ubiquitin protein ligase bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
identical protein bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
protein homodimerization activityPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
C3HC4-type RING finger domain bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
scaffold protein bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
protein bindingVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
calmodulin bindingVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
high voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
small molecule bindingVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
metal ion bindingVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
molecular function activator activityVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
high voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
voltage-gated calcium channel activity involved in cardiac muscle cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
protein bindingVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
calmodulin bindingVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
high voltage-gated calcium channel activityVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
metal ion bindingVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
alpha-actinin bindingVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
voltage-gated calcium channel activity involved in cardiac muscle cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
voltage-gated calcium channel activity involved in AV node cell action potentialVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (34)

Processvia Protein(s)Taxonomy
photoreceptor outer segmentVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
membraneVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
perikaryonVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
voltage-gated calcium channel complexVoltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
axonGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
axonGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
synaptic vesicle membraneGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
neuronal cell bodyGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
inhibitory synapseGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
extracellular exosomeGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
plasma membraneVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
Z discVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
voltage-gated calcium channel complexVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
L-type voltage-gated calcium channel complexVoltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)
plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
cell surfacePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
perinuclear region of cytoplasmPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated potassium channel complexPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
inward rectifier potassium channel complexPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
cytoplasmVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
plasma membraneVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
sarcoplasmic reticulumVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
T-tubuleVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
I bandVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
L-type voltage-gated calcium channel complexVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
voltage-gated calcium channel complexVoltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)
cytoplasmVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
plasma membraneVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
postsynaptic densityVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
membraneVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
Z discVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
dendriteVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
perikaryonVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
postsynaptic density membraneVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
L-type voltage-gated calcium channel complexVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
voltage-gated calcium channel complexVoltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (86)

Assay IDTitleYearJournalArticle
AID1525556Inhibition of human TASK3 expressed in Xenopus oocytes at 100 uM by whole cell patch clamp assay relative to control2019Journal of medicinal chemistry, 11-27, Volume: 62, Issue:22
TASK Channels Pharmacology: New Challenges in Drug Design.
AID58711The left atrial pressure was determined after 1.0 mg/kg administration with 20 mg/kg pentobarbital in the dog heart-lung preparation.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
AID127458Tested for ability to maintain self-administration after administration of 0.3 mg/kg in monkey 2037 (60.1+/-5.3)1990Journal of medicinal chemistry, Nov, Volume: 33, Issue:11
Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds.
AID1130944Hypnotic activity in rabbit1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID205269Inhibition of binding of Batrachotoxinin [3H]BTX-B to high-affinity sites on voltage-dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 100 uM1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
AID167610Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic)1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID169097Negative log of molar concentration (-log C) required to produce 50% inhibition of oxygen (oxygen uptake) on rat brain respiration in vitro1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID226648Hill value, slope calculated from GABA-current potentiation in Xenopus oocytes1997Journal of medicinal chemistry, Jan-03, Volume: 40, Issue:1
Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor.
AID698739Inhibition of [3H]R-(-)-14-induced receptor photolabeling at human FLAG-tagged beta3 GABA A receptor expressed in HEK293S cells relative to untreated control2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID38914Negative log of molar concentration (-log ED50) required to reduce cell division by 50% in Arbacia egg1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID1207759Inhibition of Cav1.2 current measured using PatchXpress automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits2013Scientific reports, , Volume: 3MICE models: superior to the HERG model in predicting Torsade de Pointes.
AID467611Dissociation constant, pKa of the compound2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID127455Tested for ability to maintain self-administration after administration of 0.3 mg/kg in monkey 2036 (44.9 +/-5.6)1990Journal of medicinal chemistry, Nov, Volume: 33, Issue:11
Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds.
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID698849Displacement of [3H]R-(-)-14 from human FLAG-tagged beta3 GABA A receptor expressed in HEK293S cells2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.
AID698738Inhibition of [3H]R-(-)-14-induced receptor photolabeling at human FLAG-tagged alpha1 GABA A receptor expressed in HEK293S cells relative to untreated control2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID127466Tested for ability to maintain self-administration after administration of 0.3 mg/kg in monkey 9079 (56.5+/-18.0)1990Journal of medicinal chemistry, Nov, Volume: 33, Issue:11
Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID576612Inhibition of human ERG2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID240319Effective concentration against GABA-evoked chloride currents mediated by human Gamma-aminobutyric acid GABA-A receptor alpha2-beta2-gamma2L expressed in Xenopus oocytes2005Journal of medicinal chemistry, Apr-07, Volume: 48, Issue:7
Synthesis, structure-activity relationships at the GABA(A) receptor in rat brain, and differential electrophysiological profile at the recombinant human GABA(A) receptor of a series of substituted 1,2-diphenylimidazoles.
AID467613Volume of distribution at steady state in human2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID240820Inhibitory concentration against IKr potassium channel2004Bioorganic & medicinal chemistry letters, Sep-20, Volume: 14, Issue:18
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
AID540211Fraction unbound in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID26320pKa value is evaluated1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID127463Tested for ability to maintain self-administration after administration of 0.3 mg/kg in monkey 3038 (53.9+/-9.3)1990Journal of medicinal chemistry, Nov, Volume: 33, Issue:11
Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds.
AID1130943Octanol-water partition coefficient, log P of nonionized form of compound1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID196544Percent of maximal extent of inhibition was calculated by fitting [35S]TBPS inhibition data to a sigmoid function (rat brain cortical P2 membranes).1997Journal of medicinal chemistry, Jan-03, Volume: 40, Issue:1
Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor.
AID62361The stroke volume was determined after 1.0 mg/kg administration with 20 mg/kg pentobarbital in the dog heart-lung preparation.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
AID1130940Retention index of the compound by HPLC method1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID24211Compound is evaluated for ionization constant log k1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID127460Tested for ability to maintain self-administration after administration of 0.3 mg/kg in monkey 3017 (76.6+/-15.9)1990Journal of medicinal chemistry, Nov, Volume: 33, Issue:11
Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds.
AID59181The heart rate was determined after 1.0 mg/kg administration with 20 mg/kg pentobarbital in the dog heart-lung preparation.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
AID56097The cardiac contractile force was determined after 1.0 mg/kg administration with 20 mg/kg pentobarbital in the dog heart-lung preparation.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1130945Inhibition of Arbacia egg cell division1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID244328Maximal efficacy for GABA-evoked chloride currents mediated by human Gamma-aminobutyric acid GABA-A receptor alpha2-beta2-gamma2L expressed in Xenopus oocytes2005Journal of medicinal chemistry, Apr-07, Volume: 48, Issue:7
Synthesis, structure-activity relationships at the GABA(A) receptor in rat brain, and differential electrophysiological profile at the recombinant human GABA(A) receptor of a series of substituted 1,2-diphenylimidazoles.
AID62363The stroke work was determined after 1.0 mg/kg administration with 20 mg/kg pentobarbital in the dog heart-lung preparation.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
AID409603Inhibition of human aquaporin 4 M23 isoform expressed in Xenopus laevis oocytes at 20 uM2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Identification of aquaporin 4 inhibitors using in vitro and in silico methods.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID71848Inhibition of [35S]TBPS binding to GABA-A receptor in rat cerebral cortex.1998Journal of medicinal chemistry, May-21, Volume: 41, Issue:11
Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological profile at recombinant human GABAA receptors.
AID127452Tested for ability to maintain self-administration after administration of 0.1 mg/kg in monkey 9083 (59.8+/-15.8)1990Journal of medicinal chemistry, Nov, Volume: 33, Issue:11
Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID698735Activation of human alpha1beta2gamma2L GABA A receptor expressed in Xenopus laevis oocytes assessed as increase in GABA-induced current response at 65 uM by two-electrode voltage clamp assay relative to untreated control2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.
AID467612Fraction unbound in human plasma2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID205268Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 10 uM1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
AID698848Displacement of [3H]R-(-)-14 from human FLAG-tagged alpha1 GABA A receptor expressed in HEK293S cells2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.
AID56235The cardiac output was determined after 1.0 mg/kg administration with 20 mg/kg pentobarbital in the dog heart-lung preparation.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID698862Anesthetic activity in Xenopus laevis tadpoles assessed as loss of of righting reflexes2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID71697Ability to allosterically modulate the binding of [35S]TBPS to gamma-aminobutyric-acid A receptor in rat brain cortical P2 membranes.1997Journal of medicinal chemistry, Jan-03, Volume: 40, Issue:1
Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor.
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1069511Retention time of the compound by chromatographic analysis2014European journal of medicinal chemistry, Mar-03, Volume: 74N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID493017Wombat Data for BeliefDocking1997Journal of medicinal chemistry, Jan-03, Volume: 40, Issue:1
Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9,568)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906938 (72.51)18.7374
1990's1377 (14.39)18.2507
2000's758 (7.92)29.6817
2010's395 (4.13)24.3611
2020's100 (1.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 91.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index91.33 (24.57)
Research Supply Index9.25 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index171.48 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (91.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials175 (1.70%)5.53%
Reviews160 (1.56%)6.00%
Case Studies126 (1.23%)4.05%
Observational8 (0.08%)0.25%
Other9,803 (95.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Qualitative Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography [NCT02250820]Phase 1280 participants (Actual)Interventional2014-11-30Completed
Dexmedetomidine Versus Pentobarbital Sedation Protocol for Non-painful Procedural Sedation in Pediatrics [NCT00878345]0 participants (Actual)Interventional2009-11-30Withdrawn(stopped due to Study was never opened)
Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension. [NCT00622570]Phase 344 participants (Actual)Interventional2002-05-31Terminated(stopped due to Slowly recruitment rate. Intermediate analysis)
GHB: Effects, Withdrawal and Treatment [NCT00123578]Phase 1/Phase 20 participants (Actual)Interventional2004-08-31Withdrawn(stopped due to Unable to recruit adaquate number of GHB dependent subjects)
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care [NCT01431326]3,520 participants (Actual)Observational2011-11-30Completed
Comparison of Sedation Using Pentobarbital or Chlorpromazine in Pediatric Non-invasive Imaging Procedure: A Before and After Study [NCT04350528]254 participants (Anticipated)Observational2020-04-30Not yet recruiting
Physiological, Behavioral and Subjective Effects of Drugs (GHB) [NCT00058955]Phase 120 participants (Anticipated)Interventional2003-08-31Completed
A Randomized Clinical Trial for the Treatment of Refractory Status Epilepticus [NCT00265616]Phase 323 participants (Actual)Interventional2006-05-31Terminated(stopped due to Insufficient recruitment)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00265616 (6) [back to overview]Clinical Outcome at Day 21
NCT00265616 (6) [back to overview]Intubation Time in Survivors
NCT00265616 (6) [back to overview]Patients With Hypotension Requiring Specific Treatment
NCT00265616 (6) [back to overview]Patients With Infectious Complications Requiring Specific Treatment
NCT00265616 (6) [back to overview]Patients With Propofol Infusion Syndrome
NCT00265616 (6) [back to overview]Refractory Status Epilepticus Controlled With First Course of Study Drug

Clinical Outcome at Day 21

Return to baseline clinical conditions (i.e.: no new handicap, no death) (NCT00265616)
Timeframe: 21 days

Interventionparticipants (Number)
Propofol5
Thiopental/Pentobarbital3

[back to top]

Intubation Time in Survivors

(NCT00265616)
Timeframe: Up to 3 months

Interventiondays (Median)
Propofol4
Thiopental/Pentobarbital13.5

[back to top]

Patients With Hypotension Requiring Specific Treatment

(NCT00265616)
Timeframe: 10 days

Interventionparticipants (Number)
Propofol7
Thiopental/Pentobarbital5

[back to top]

Patients With Infectious Complications Requiring Specific Treatment

(NCT00265616)
Timeframe: 10 days

Interventionparticipants (Number)
Propofol7
Thiopental/Pentobarbital6

[back to top]

Patients With Propofol Infusion Syndrome

Propofol infusion syndrome (PRIS) is a severe metabolic alteration with elevation of lactate, CK, and triglycerides. (NCT00265616)
Timeframe: 10 days

Interventionparticipants (Number)
Propofol1
Thiopental/Pentobarbital0

[back to top]

Refractory Status Epilepticus Controlled With First Course of Study Drug

Control of status epilepticus refractory to benzodiazepines and a first antiepileptic drug after administration of the study drug; dichotomous assessment (yes/no) (NCT00265616)
Timeframe: after return of continuous EEG activity (typically after 36 hours - 5 days)

Interventionparticipants (Number)
Propofol6
Thiopental/Pentobarbital2

[back to top]